81 results on '"Giselle K Perez"'
Search Results
2. Testing psychosocial mediators of a mind–body resiliency intervention for cancer survivors
- Author
-
Lucy Finkelstein-Fox, Autumn W. Rasmussen, Daniel L. Hall, Giselle K. Perez, Amy H. Comander, Jeffrey Peppercorn, Reid Anctil, Cathy Wang, and Elyse R. Park
- Subjects
Oncology - Published
- 2022
3. Longitudinal Electronic Cigarette Use Among Patients Recently Diagnosed With Cancer Enrolled in a Smoking Cessation Trial
- Author
-
Sara Kalkhoran, Joanna M Streck, Gina R Kruse, Nancy A Rigotti, Giselle K Perez, Susan Regan, Colin J Ponzani, Alona Muzikansky, Elyse R Park, and Jamie S Ostroff
- Subjects
Public Health, Environmental and Occupational Health - Abstract
Introduction Many cancer patients who smoke report concurrent e-cigarette use. Using a mixed-methods approach, we aimed to (1) describe longitudinal e-cigarette use over 6 months after a cancer diagnosis and (2) assess the association between e-cigarette use and smoking cessation, among cancer patients in a smoking cessation trial. Aims and Methods Data were from a 2-site randomized controlled trial of Standard (brief counseling) versus Intensive treatment (sustained counseling plus smoking cessation medication) in individuals who smoke recently diagnosed with cancer. Participants (n = 303) reported e-cigarette use at baseline, 3 months, and 6 months. Biochemically-verified past 7-day cigarette abstinence was collected at 6 months. Qualitative interviews at 6 months explored factors related to e-cigarette use. Results E-cigarette use prevalence was highest between baseline and 3 months (16%) and declined over time. Participants using e-cigarettes at follow-up had higher baseline cigarette dependence and smoked more heavily. Multivariable analyses found no significant association between follow-up e-cigarette use and 6-month cigarette abstinence. E-cigarette use at follow-up was higher in the Standard versus Intensive treatment group (p = .003 and .001 at 3 and 6 mo, respectively). Smoking cessation and health concerns were primary reasons for using e-cigarettes. Conclusions Among individuals who smoke recently diagnosed with cancer and enrolled in a smoking cessation intervention trial, e-cigarette use during trial participation was not associated with smoking abstinence. Individuals who chose to use e-cigarettes were less likely to be receiving intensive cessation support as part of the trial. Further studies are needed to evaluate the association between e-cigarette use and smoking cessation in cancer patients. Implications E-cigarette use was not associated with cigarette abstinence at 6 months among adults who smoke recently diagnosed with cancer enrolled in a smoking cessation trial. Individuals with easier access to evidence-based smoking cessation treatment may be less likely to use e-cigarettes.
- Published
- 2022
4. 'I thought there would be more I understood': health insurance literacy among adolescent and young adult cancer survivors
- Author
-
Austin R. Waters, Karely Mann, Echo L. Warner, Perla L. Vaca Lopez, Heydon K. Kaddas, Nicole Ray, Tomoko Tsukamoto, Douglas B. Fair, Mark A. Lewis, Giselle K. Perez, Elyse R. Park, and Anne C. Kirchhoff
- Subjects
Oncology - Published
- 2022
5. Adaptation and Development of a Health Insurance Education Program for Adolescent and Young Adult Cancer Patients
- Author
-
Perla L. Vaca Lopez, Echo L. Warner, Austin R. Waters, Karely M. van Thiel Berghuijs, John S. Anderson, Nicole Ray, Tomoko Tsukamoto, Heydon K. Kaddas, Douglas Fair, Mark Lewis, Elyse R. Park, Giselle K. Perez, and Anne C. Kirchhoff
- Subjects
Oncology ,Pediatrics, Perinatology and Child Health - Published
- 2023
6. Characteristics and Experiences of Parents of Children with Learning and Attention Disabilities and Autism Spectrum Disorder: A Mixed Methods Study
- Author
-
Emma Chad-Friedman, Karen A. Kuhlthau, Rachel A. Millstein, Giselle K. Perez, Christina M. Luberto, Lara Traeger, Jacqueline Proszynski, and Elyse Park
- Subjects
Social Psychology ,mental disorders ,behavioral disciplines and activities ,Social Sciences (miscellaneous) - Abstract
Parents of children with learning and attention disorders (LAD) and autism spectrum disorder (ASD) experience chronic parenting stress due to the challenges in raising a child with special needs. We used a mixed methods design to examine characteristics and experiences of stress and coping among parents of children with LAD and ASD. We conducted 20 semi-structured focus group interviews with parents of children with LAD ( n = 11) and ASD ( n = 9) and administered a battery of self-report measures of stress and coping to parents of LAD ( n = 53) and ASD ( n = 51) enrolled in a pilot trial. Qualitative findings showed that parents of children with LAD and ASD largely experienced similar sources of stress, but with different intensities due to their children's different difficulties. Quantitative findings reflected high levels of distress among parents of children with LAD and ASD, with parents of children with ASD demonstrating higher distress and poorer overall sleep quality. Stressors experienced by parents of children with ASD arose from more overt challenges associated with having a child with more visible challenges. Parents of children with LAD experienced more subtle challenges of having a child who is less overtly impaired. Findings will aid in the development of targeted stress management interventions.
- Published
- 2021
7. Internalized stigma among cancer patients enrolled in a smoking cessation trial: The role of cancer type and associations with psychological distress
- Author
-
Jamie S. Ostroff, Elyse R. Park, Julia Rabin, Erica T. Warner, Giselle K. Perez, and Christina M. Luberto
- Subjects
medicine.medical_specialty ,Social stigma ,business.industry ,medicine.medical_treatment ,Social Stigma ,Head and neck cancer ,Psycho-oncology ,Stigma (botany) ,Cancer ,Experimental and Cognitive Psychology ,Disease ,Psychological Distress ,medicine.disease ,Article ,Psychiatry and Mental health ,Cross-Sectional Studies ,Oncology ,Head and Neck Neoplasms ,Internal medicine ,Humans ,Medicine ,Smoking cessation ,Smoking Cessation ,business ,Depression (differential diagnoses) - Abstract
PURPOSE: Cancer patients who smoke may experience significant stigma due both to their disease, and negative attitudes and beliefs regarding smoking. We investigated whether internalized stigma differed between currently smoking cancer patients diagnosed with lung or head and neck cancers, other smoking related cancers, and non smoking-related cancers, and whether internalized stigma was associated with psychological distress. METHODS: This cross-sectional analysis used baseline data on 293 participants enrolled in a multi-site randomized smoking cessation intervention trial of patients with recently diagnosed cancer. Internalized stigma was assessed using five Internalized Shame items from the Social Impact of Disease Scale. Smoking-related cancers included lung, head and neck, esophageal, bladder, kidney, liver, pancreatic, colorectal, anal, small intestinal, gastric, and cervical. We used multivariable linear regression to examine whether mean internalized stigma levels differed between individuals with lung and head and neck cancers, other smoking-related cancers, and non smoking-related cancers, adjusting for potential confounders. We further examined the association of internalized stigma with depression, anxiety, and perceived stress, overall and among cancer type groups. RESULTS: Thirty-nine percent of participants were diagnosed with lung or head and neck cancer, 21% with another smoking-related cancer, and 40% with a non smoking-related cancer. In multivariable-adjusted models, participants with lung or head and neck cancers (11.6, 95% confidence intervals (CI) = 10.8-12.2; p < 0.0001) or other smoking-related cancers (10.7, 95% CI = 9.8-11.7; p = 0.03) had higher mean internalized stigma scores compared to those non-smoking-related cancers (9.3, 95% CI = 8.6-10.0). We observed similar positive associations between internalized stigma and depressive symptoms, anxiety, and perceived stress among participants with smoking-related and non smoking-related cancers. CONCLUSIONS: Among smokers, those with smoking-related cancers experienced the highest levels of internalized stigma, and greater internalized stigma was associated with greater psychological distress across cancer types. Providers should assess patients for internalized and other forms of stigma, refer patients for appropriate psychosocial support services, and address stigma in smoking cessation programs.
- Published
- 2021
8. Patients With Serious Mental Illness Can Engage in Tobacco Treatment Trials and Tobacco Cessation Interventions During Cancer Treatment
- Author
-
Eleanor B. Steffens, Elyse R. Park, Alona Muzikansky, Joanna M. Streck, Jamie S. Ostroff, Autumn W. Rasmussen, Colin Ponzani, Giselle K. Perez, Susan Regan, Nancy A. Rigotti, and Kelly E. Irwin
- Subjects
Oncology ,Oncology (nursing) ,Health Policy - Abstract
PURPOSE: More than half of individuals with serious mental illness (SMI) smoke, contributing to premature cancer mortality. A cancer diagnosis provides an opportunity to assist with smoking cessation; however, supportive oncology trials frequently exclude patients with SMI. To fill this gap, we examined differences in engagement and tobacco cessation in a pragmatic clinical trial. METHODS: We recruited 303 participants from two National Cancer Institute–designated Comprehensive Cancer Centers, of which 10% had prior diagnoses of SMI (major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders). We compared self-reported smoking behaviors, patient attitudes and beliefs about cessation, and rates of trial completion, engagement, and smoking abstinence among recently diagnosed patients with cancer with and without SMI. Six months after trial completion, we completed qualitative interviews on barriers and facilitators to tobacco cessation in a random sample of participants with SMI. RESULTS: Trial participants with SMI had similar motivation to quit smoking as those without SMI. Additionally, participants with SMI had a similar ability to engage in a tobacco treatment trial (6.5 counseling sessions completed v 7.3 sessions) and benefit from tobacco treatment as those without SMI (32.3% v 27.8% 6-month quit rates). CONCLUSION: Patients with cancer and SMI were able to engage in and benefit from a tobacco cessation trial integrated into cancer care. A cancer diagnosis provides an opportunity to assist patients with SMI with smoking cessation referrals and treatment. Pragmatic supportive oncology trials that include a diverse population of adults with SMI are needed to inform care delivery and improve cancer outcomes for patients with SMI and cancer.
- Published
- 2022
9. Resiliency Intervention for Siblings of Children With Autism Spectrum Disorder: A Randomized Pilot Trial
- Author
-
Karen A. Kuhlthau, Lara Traeger, Christina M. Luberto, Giselle K. Perez, Brett M. Goshe, Lucy Fell, Dorothea Iannuzzi, and Elyse R. Park
- Subjects
Pediatrics, Perinatology and Child Health - Published
- 2022
10. Moderators of a resiliency group intervention for frontline clinicians during the COVID-19 pandemic
- Author
-
Christina M. Luberto, Dustin J. Rabideau, Maurizio Fava, Louisa G. Sylvia, Darshan H. Mehta, Joanna M. Streck, Sara E. Looby, Sydney Crute, Evan A. Albury, Helen Mizrach, Gregory L. Fricchione, Sabine Wilhelm, Mary Susan Convery, Daniel L. Hall, Giselle K. Perez, Nevita George, and Elyse R. Park
- Subjects
Stress management ,Mindfulness ,Short Communication ,media_common.quotation_subject ,COVID-19 pandemic ,03 medical and health sciences ,0302 clinical medicine ,Intervention (counseling) ,Adaptation, Psychological ,medicine ,Humans ,Pandemics ,media_common ,Relaxation (psychology) ,SARS-CoV-2 ,business.industry ,Frontline clinicians ,COVID-19 ,Loneliness ,Resilience, Psychological ,Resiliency program ,Confidence interval ,030227 psychiatry ,Psychiatry and Mental health ,Clinical Psychology ,Stress coping ,Anxiety ,Psychological resilience ,medicine.symptom ,business ,Stress, Psychological ,030217 neurology & neurosurgery ,Clinical psychology - Abstract
Background To mitigate the psychological burdens of COVID-19 for frontline clinicians (FCs), we adapted an existing evidence-based resiliency program, Stress Management and Resilience Training Relaxation Response Program (SMART-3RP), for FCs. This analysis explores moderators of stress coping to determine which subgroups of FCs benefited most from SMART-3RP. Methods 102 FCs from Mass General Brigham hospitals engaged in the adapted SMART-3RP. Assessments were completed at group entry (Week 0) and completion (Week 4). The primary outcome was stress coping, and we examined 15 possible baseline moderators. We fit linear mixed effects regression models and assessed potential baseline moderators using a likelihood ratio test. We report model-based estimates and confidence intervals for each moderator-by-time interaction (i.e., differential effect), where positive/negative values indicate more/less improvement in average perceived stress coping. Results Stress coping improved from Week 0 to Week 4 (mean improvement [95% CI] = 0.9 [0.6 to 1.2]). FCs with higher anxiety (differential effect [95% CI] = 0.3 [0.1 to 0.4]), depression (0.4 [0.2 to 0.6]), and loneliness (0.4 [0.1 to 0.6]), but lower levels of mindfulness (CAMS-Rfocus: 1.0 [0.4 to 1.6]; CAMS-Raccept: 1.3 [0.7 to 2.0]) and self-compassion (0.4, [0.1 to 0.8]) at baseline experienced greater benefits in perceived stress coping from the SMART-3RP. Baseline health uncertainty along with sociodemographic and work characteristics did not moderate stress coping. Discussion Results highlight particular sub-populations of FCs that may benefit more from a stress management intervention, especially during emergency responses (e.g., COVID-19 pandemic).
- Published
- 2021
11. Resiliency Intervention for Siblings of Children with ASD: A Randomized Pilot Trial
- Author
-
Karen A, Kuhlthau, Lara, Traeger, Christina M, Luberto, Giselle K, Perez, Brett M, Goshe, Lucy, Fell, Dorothea, Iannuzzi, and Elyse R, Park
- Abstract
Neurotypical siblings (NT siblings) of children with autism spectrum disorder (ASD) are at elevated risk for emotional distress and adjustment problems. Resiliency is the ability to cope and adapt with ongoing stressors. We conducted a randomized waitlist-controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of an adapted virtual mind-body resiliency group intervention for teen NT siblings of children with ASD.We modified the Stress Management and Resiliency Training-Relaxation Response Resiliency Program for NT siblings of children with ASD (SibChat). We randomly assigned teens (aged 14-17) to immediate intervention (IG) vs. waitlist control (WLC). The intervention included eight 60-minute weekly video conference group sessions. We assessed feasibility (enrollment, attendance, and retention) and acceptability (post treatment survey and weekly relaxation response practice). We explored group differences in pre-post change scores for 1) stress coping (Measure of Current Status-A) and 2) resiliency (Current Experiences Scale) using independent samples t-tests and effect size calculations.We enrolled 83% of screened eligible teens. 90% IG and 75% WLC participants attended at least 6/8 sessions. Among IG participants who completed the post treatment survey, 79% reported practicing relaxation response exercises at least "a few times a week". Comparing change in baseline to time 1, the IG showed better relative changes than the WLC group in stress coping (d=0.60) and resiliency (d=0.24).Our pilot trial showed promising feasibility, acceptability, and preliminary efficacy of SibChat on at least one of the two primary outcomes supporting further testing of the SibChat intervention.This paper provides new information about an intervention designed to address resiliency and stress coping in a group of teen siblings.US National Library of Medicine.NCT04369417. https://clinicaltrials.gov/ct2/show/NCT04369417.
- Published
- 2022
12. Challenges and Growth: Lived Experience of Adolescents and Young Adults (AYA) with a Sibling with ASD
- Author
-
Dorothea Iannuzzi, Lucy Fell, Elyse R. Park, Brett M. Goshe, Sydney Crute, Christina M. Luberto, Karen Kuhlthau, Lara Traeger, and Giselle K. Perez
- Subjects
media_common.quotation_subject ,05 social sciences ,Stressor ,Empathy ,Hypervigilance ,medicine.disease ,Sibling relationship ,Developmental psychology ,03 medical and health sciences ,0302 clinical medicine ,Developmental and Educational Psychology ,medicine ,Autism ,0501 psychology and cognitive sciences ,Young adult ,Sibling ,medicine.symptom ,Psychology ,030217 neurology & neurosurgery ,Neurotypical ,050104 developmental & child psychology ,media_common - Abstract
Adolescent and young adult (AYA) siblings of individuals with autism experience unique challenges that can promote both growth and emotional maladjustment. This study explored sibling and parent reports of siblings' lived experiences and identified learning, stressors, and concerns from those experiences. 20 neurotypical (NT) AYA siblings (ages 13-24), and 21 parents were interviewed. Themes that emerged from the data analysis included: (1) learning, empathy, and compassion (2) relationship between the degree of functional impairment and the nature of the sibling relationship; (3) reluctance to share information about siblings with peers; (4) hypervigilance associated with unpredictable behavior; (5) worries and concerns about the future. These findings contribute to the existing literature on the impact and nature of neurotypical siblings' lived experience.
- Published
- 2021
13. Material, behavioral, and psychological financial hardship among survivors of childhood cancer in the Childhood Cancer Survivor Study
- Author
-
Gregory T. Armstrong, Kelly A. Hyland, Anne C. Kirchhoff, Giselle K. Perez, Leslie L. Robison, Ryan D. Nipp, Karen Kuhlthau, Douglas Fair, Wendy M. Leisenring, Julia Rabin, Elyse R. Park, Kevin C. Oeffinger, and Paul C. Nathan
- Subjects
Finance ,Cancer Research ,business.industry ,Childhood cancer ,Coping behavior ,Childhood Cancer Survivor Study ,Odds ratio ,Logistic regression ,Confidence interval ,03 medical and health sciences ,Brain radiation ,0302 clinical medicine ,Oncology ,030220 oncology & carcinogenesis ,Medicine ,030212 general & internal medicine ,business ,human activities ,Medical expenses ,health care economics and organizations - Abstract
Background Medical financial burden includes material, behavioral, and psychological hardship and has been underinvestigated among adult survivors of childhood cancer. Methods A survey from 698 survivors and 210 siblings from the Childhood Cancer Survivor Study was analyzed. The intensity of financial hardship was estimated across 3 domains: 1) material, including conditions that arise from medical expenses; 2) behavioral, including coping behaviors to manage medical expenses; and 3) psychological hardship resulting from worries about medical expenses and insurance, as measured by the number of instances of each type of financial hardship (0, 1-2, and ≥3 instances). Multivariable logistic regressions were conducted to examine the clinical and sociodemographic predictors of experiencing financial hardship (0-2 vs ≥3 instances). Results The intensity of financial hardship did not significantly differ between survivors and siblings. Survivors reported more instances of material hardship than siblings (1-2 instances: 27.2% of survivors vs 22.6% of siblings; ≥3 instances: 15.9% of survivors vs 11.4% siblings; overall P = .03). In multivariable regressions, insurance was protective against all domains of financial hardship (behavioral odds ratio [OR], 0.12; 95% confidence interval [CI], 0.06-0.22; material OR, 0.37; 95% CI, 0.19-0.71; psychological OR, 0.10; 95% CI, 0.05-0.21). Survivors who were older at diagnosis, female, and with chronic health conditions generally had higher levels of hardship. Brain radiation and alkylating agents were associated with higher levels of hardship. Conclusions Material, behavioral, and psychological financial burden among survivors of childhood cancer is common.
- Published
- 2021
14. HIAYA CHAT study protocol: a randomized controlled trial of a health insurance education intervention for newly diagnosed adolescent and young adult cancer patients
- Author
-
Karely Mann, Austin R. Waters, Elyse R. Park, Giselle K. Perez, Perla L. Vaca Lopez, Heydon K. Kaddas, Echo L. Warner, Nicole Ray, Tomoko Tsukamoto, Karlie Allen, Ben Haaland, Douglas B. Fair, Mark A. Lewis, and Anne C. Kirchhoff
- Subjects
Adult ,Young Adult ,Insurance, Health ,Adolescent ,Neoplasms ,Surveys and Questionnaires ,Medicine (miscellaneous) ,Humans ,Patient Navigation ,Pharmacology (medical) ,Health Literacy ,Randomized Controlled Trials as Topic - Abstract
Background For adolescent and young adult (AYA) cancer patients aged 18 to 39 years, health insurance literacy is crucial for an effective use of the health care system. AYAs often face high out-of-pocket costs or have unmet health care needs due to costs. Improving health insurance literacy could help AYAs obtain appropriate and affordable health care. This protocol illustrates a randomized controlled trial testing a virtual health insurance education intervention among AYA patients. Methods This is a two-arm multisite randomized controlled trial. A total of 80 AYAs diagnosed with cancer in the Mountain West region will be allocated to either usual navigation care or tailored health insurance education intervention with a patient navigator that includes usual care. All participants will complete a baseline and follow-up survey 5 months apart. The primary outcomes are feasibility (number enrolled and number of sessions completed) and acceptability (5-point scale on survey measuring satisfaction of the intervention). The secondary outcomes are preliminary efficacy measured by the Health Insurance Literacy Measure and the COmprehensive Score for financial Toxicity. Discussion This trial makes a timely contribution to test the feasibility and acceptability of a virtual AYA-centered health insurance education program. Trial registration ClinicalTrials.gov NCT04448678. Registered on June 26, 2020
- Published
- 2022
15. Corrigendum to 'Examining the effects of stress and psychological distress on smoking abstinence in cancer patients' [Prev. Med. Rep. 23 (2021) 101402]
- Author
-
Joanna M. Streck, Christina M. Luberto, Alona Muzikansky, Sarah Skurla, Colin J. Ponzani, Giselle K. Perez, Daniel L. Hall, Adam Gonzalez, Brittain Mahaffey, Nancy A. Rigotti, Jamie S. Ostroff, and Elyse R. Park
- Subjects
Public Health, Environmental and Occupational Health ,Medicine ,Health Informatics ,Corrigendum - Abstract
Cancer patients who smoke report more stress and psychological distress than patients who do not smoke. It is unclear how these emotional symptoms may modify smoking behavior in cancer patients. We examined the influence of a smoking cessation intervention for cancer patients on stress and distress, and the effects of these symptoms on smoking abstinence.Mixed-methods secondary analysis of data from the Smokefree Support Study, a two-site randomized controlled trial examining the efficacy of Intensive (IT; n = 153) vs. Standard Treatment (ST; n = 150) for smoking cessation in newly diagnosed cancer patients. Stress coping, perceived stress, distress, and anxiety were self-reported at baseline, 3, and 6 months. Abstinence was biochemically-confirmed at 6 months. A subset of patients (n = 72) completed qualitative exit-interviews.Patients were on average, 58 years old, 56% female, and smoked a median of 10 cigarettes/day. There were no significant treatment group × time interactions or main effects of treatment group on stress or distress measures (p's 0.05), however there were significant main effects of time suggesting symptom improvements on each measure in both study groups (p's 0.05). In adjusted logistic regression models, lower levels anxiety at 3 months predicted confirmed smoking abstinence at 6 months (p = .03). Qualitatively, at 6 months, patients reported their stress and smoking were connected and that the cessation counseling was helpful.Cancer patients enrolled in a smoking cessation trial report decreases in stress, distress and anxiety over time, and anxiety symptoms may impact smoking cessation success at follow-up resulting in an important intervention target.
- Published
- 2022
16. Moving forward on all fronts: impact, patterns, and barriers to exercise in cancer survivors and patients living with advanced disease
- Author
-
Jessica Garton, Elizabeth O'Donnell, Julia Rabin, Jeffrey Peppercorn, Kit M. Quain, Sasha E. Knowlton, Giselle K. Perez, Elyse R. Park, and Nora Horick
- Subjects
medicine.medical_specialty ,business.industry ,Pain medicine ,Nursing research ,Cancer ,medicine.disease ,Advanced cancer ,03 medical and health sciences ,Health problems ,0302 clinical medicine ,Oncology ,030220 oncology & carcinogenesis ,Advanced disease ,medicine ,Physical therapy ,Lower prevalence ,In patient ,030212 general & internal medicine ,business - Abstract
Exercise is recommended for all patients with cancer, but there has been limited study of exercise habits in patients across the spectrum of illness. This pragmatic survey aimed to identify the unmet supportive care needs, self-reported symptoms, and exercise habits among both cancer survivors and patients living with advanced disease to determine adherence to exercise guidelines and to identify barriers and opportunities to improve exercise. An anonymous cross-sectional self-administered paper survey was distributed to patients with cancer presenting for oncology clinic visits at an academic cancer center. Survey measures included presence of symptoms and health problems in addition to weekly time spent exercising, change in exercise levels since diagnosis, interest in exercise, and self-reported barriers. Participants reporting at least 150 min of exercise per week were characterized as adherent to guidelines. Among 640 survey respondents, 570 (89%) completed questions about exercise. Only 44% of cancer survivors and 34% of patients living with advanced disease met current guidelines. Survivors who met exercise guidelines had a lower prevalence of fatigue and memory impairments, but this finding was not seen among patients with advanced cancer. Over 70% of patients with advanced disease and 47% of survivors reported decreasing exercise post-diagnosis compared to pre-diagnosis. Prominent barriers to exercise among both groups included burden of illness and time constraints but interest in increasing exercise was high. There is an opportunity to improve exercise and related outcomes among a large percentage of both cancer survivors and patients living with advanced disease.
- Published
- 2020
17. Testing psychosocial mediators of a mind-body resiliency intervention for cancer survivors
- Author
-
Lucy, Finkelstein-Fox, Autumn W, Rasmussen, Daniel L, Hall, Giselle K, Perez, Amy H, Comander, Jeffrey, Peppercorn, Reid, Anctil, Cathy, Wang, and Elyse R, Park
- Subjects
Adult ,Cancer Survivors ,Mind-Body Therapies ,Neoplasms ,Adaptation, Psychological ,Humans ,Resilience, Psychological ,Mindfulness ,Stress, Psychological - Abstract
Group-based mind-body interventions such as the Stress Management and Resiliency Training-Relaxation Response Resiliency Program (SMART-3RP) hold promise for enhancing resiliency among cancer survivors. Mechanisms underlying improvements in psychological outcomes are theoretically established but remain unexamined empirically.Adult cancer survivors (n = 105) participating in the SMART-3RP completed surveys of resiliency and five hypothesized mediators: coping (ability to relax physical tension and assertive social support-seeking), mindfulness, positive affect, and worry. Pre-post intervention changes were assessed using repeated-measures t-tests. Bivariate correlations between change scores and a more conservative within-person parallel mediation model tested covariance between resiliency and mediators.Participants experienced moderate to large improvements in all patient-reported outcomes (ds = 1.01-0.46). Increased resiliency was significantly associated with increases in mindfulness, positive affect, and assertive social support-seeking (rs = 0.36-0.50); smaller associations with increased relaxation and decreased worry were not significant. Mindfulness and positive affect explained the largest proportion of variance in resiliency increase in the full multivariate model.Cancer survivors completing the SMART-3RP had increased resiliency, which was associated with improvements in mindfulness, positive affect, and the ability to assertively seek social support. Enhancing mindfulness and positive affect were critical components for enhancing resiliency. Implications for resiliency interventions with cancer survivors are discussed.
- Published
- 2022
18. Randomized Waitlist-Control Trial of a Web-Based Stress-Management and Resiliency Program for Adolescent and Young Adult Cancer Survivors: Protocol for the Bounce Back Study (Preprint)
- Author
-
Helen Mizrach, Brett Goshe, Elyse R Park, Christopher Recklitis, Joseph A Greer, Yuchiao Chang, Natasha Frederick, Annah Abrams, Mary D Tower, Emily A Walsh, Mary Huang, Lisa Kenney, Alan Homans, Karen Miller, John Denninger, Ghazala Naheed Usmani, Jeffrey Peppercorn, and Giselle K Perez
- Abstract
BACKGROUND The emotional health of adolescent and young adult (AYA) cancer survivors is compromised both during and after cancer treatment. Targeted programs designed to support AYAs’ ability to cope with stress in the years following treatment completion are lacking. Mind-body programs may ameliorate the negative psychological and emotional effects of stress and assist AYAs with managing the psychosocial challenges of early survivorship. OBJECTIVE Our randomized waitlist-control trial aims to assess the feasibility, acceptability, and preliminary efficacy of a virtual group program (Bounce Back) to promote stress management and resiliency among posttreatment AYAs. METHODS Bounce Back is a stress management and resiliency program delivered via videoconference by a trained mental health clinician. Sessions were adapted from an evidence-based mind-body program (Stress Management and Resiliency Training - Relaxation Response Resiliency Program [SMART-3RP]) grounded in relaxation response elicitation, mindfulness, cognitive behavioral therapy, and positive psychology. Seventy-two AYAs (diagnosed with cancer between ages 14 years and 29 years and had completed cancer treatment within the last 5 years) were randomly assigned to the Bounce Back program or waitlist-control group and completed assessments at baseline, 3 months postbaseline, and 6 months postbaseline. The primary aim of the study is to determine the feasibility and acceptability of the Bounce Back program. Descriptive statistics, including means, frequencies, and ranges supplemented by qualitative exit interview feedback will be used to characterize the sample and to summarize feasibility and acceptability. The exploratory aims are to evaluate the preliminary effects of the program on stress coping and psychosocial outcome measures (ie, anxiety, depression) collected across the 3 time points. RESULTS This study was funded by the National Cancer Institute in July 2017. Study procedures were approved by the Dana-Farber Harvard Cancer Center Institutional Review Board in October 2018 (Protocol 18-428). The randomized trial was conducted from July 2019 to March 2021. Quantitative data collection is complete, and qualitative exit interview data collection is ongoing. Results are expected to be published in peer-reviewed journals and presented at local, national, or international meetings in the coming years. CONCLUSIONS Few evidence-based programs exist that tackle the key transitional issues faced by AYA cancer survivors. Future analyses will help us determine the feasibility and acceptability of the Bounce Back program and its impact on AYA stress coping and psychological well-being. CLINICALTRIAL ClinicalTrials.gov NCT03768336; https://clinicaltrials.gov/ct2/show/NCT03768336 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/34033
- Published
- 2021
19. 'I thought there would be more I understood': health insurance literacy among adolescent and young adult cancer survivors
- Author
-
Austin R, Waters, Karely, Mann, Echo L, Warner, Perla L, Vaca Lopez, Heydon K, Kaddas, Nicole, Ray, Tomoko, Tsukamoto, Douglas B, Fair, Mark A, Lewis, Giselle K, Perez, Elyse R, Park, and Anne C, Kirchhoff
- Subjects
Adult ,Male ,Young Adult ,Insurance, Health ,Adolescent ,Cancer Survivors ,Neoplasms ,Humans ,Female ,Survivors ,Health Literacy - Abstract
Health insurance literacy is crucial for navigating the US healthcare system. Low health insurance literacy may be especially concerning for adolescent and young adult (AYA) cancer survivors. To describe AYAs' health insurance literacy, we conducted semi-structured interviews with AYA survivors, on and off of treatment.We interviewed 24 AYA cancer survivors (aged 18-39 years) between November 2019 and March 2020. Interviews were recorded, transcribed, and quality-checked. Using two cycles of structured coding, we explored AYAs' health insurance literacy and examined thematic differences by policy holder status and age.AYAs were 58.3% female, 79.2% non-Hispanic White, 91.7% heterosexual, and 62.5% receiving cancer treatment. Most participants had employer-sponsored health insurance (87.5%), and 41.7% were their own policy holder. Four themes emerged; in the first theme, most AYAs described beginning their cancer treatment with little to no understanding of their health insurance. This led to the three subsequent themes in which AYAs reported: unclear expectations of what their insurance would cover and their out-of-pocket costs; learning about insurance and costs by trial and error; and how their health insurance literacy negatively impacted their ability to navigate the healthcare system.Our findings, while requiring confirmation in larger samples and in other health systems, suggest that the health insurance literacy needed to navigate insurance and cancer care is low among US AYA survivors and may have health and financial implications. As the burden of navigating insurance is often put on patients, health insurance education is an important supportive service for AYA survivors on and off of treatment.
- Published
- 2021
20. A pilot intervention to improve health insurance literacy and financial toxicity among recently diagnosed adolescents and young adults with cancer
- Author
-
Anne C. Kirchhoff, Karely Mann, Austin R. Waters, Heydon K. Kaddas, Giselle K. Perez, Echo L. Warner, Perla L. Vaca Lopez, Nicole Ray, Amy Chevrier, Karlie Allen, Douglas Beaty Fair, Tomoko Tsukamoto, Mark Andrew Lewis, Ben Haaland, and Elyse R. Park
- Subjects
Cancer Research ,Oncology - Abstract
218 Background: Adolescents and young adults (AYAs; ages 18-39) with cancer report worries about costs and feeling uninformed about their insurance, which may impair their ability to navigate the health care system, use their insurance, and manage costs. We conducted a pilot randomized controlled trial (RCT) to assess a virtually delivered health insurance navigation intervention (“CHAT”) to improve health insurance literacy (HIL) and knowledge, increase awareness of insurance protections in the Affordable Care Act (ACA), and reduce financial toxicity and stress. Methods: CHAT is a 4-session program delivered by a patient navigator. Session content included learning about insurance, navigating your plan, insurance-related laws, & managing care costs. Eligible participants had access to a wireless device, were within their first year of cancer diagnosis, and were treated at oncology sites from the University of Utah Healthcare and Intermountain Healthcare systems. We assessed feasibility and preliminary efficacy of CHAT compared to usual navigation care, including HIL (9 items on confidence using insurance), insurance knowledge (13 items on terms such as deductible & copay), ACA protections (8 items), Perceived Stress Scale (PSS; 4 items), and COmprehensive Score for financial Toxicity (COST; 11 items) using t-tests. Results: From November 2020 to January 2022, 86 AYAs enrolled (46.2% approached consented); 68.6% were female, 72.1% white, 18.6% Hispanic, 34.9% age 18-25, 65.1% age 26-39, 83.7% had private insurance, and 10.5% public. Mean baseline HIL scores were 22.6 (range = 9-33, SD = 5.5). At baseline, 65.1% of participants were unaware of the ACA provision allowing appeals for coverage denials. 64.4% of intervention participants completed all 4 sessions; 86.0% completed the 5-month follow-up survey with data collection ongoing (74/86). At follow-up, compared to usual navigation care, CHAT participants had improvements in HIL, knowledge of insurance, and knowledge of ACA provisions (Table). While PSS improved more for CHAT than usual care, COST did not differ. Conclusions: Results support the feasibility and preliminary efficacy of CHAT with related improvements in HIL and knowledge of the ACA. Clinical trial information: NCT04448678. [Table: see text]
- Published
- 2022
21. A Virtual Resiliency Intervention for Parents of Children with Autism: A Randomized Pilot Trial
- Author
-
Christina M. Luberto, Karen Kuhlthau, Emma Chad-Friedman, Giselle K. Perez, Jacqueline Proszynski, Rachel A. Millstein, Elyse R. Park, Olivia J. Lindly, and Lara Traeger
- Subjects
Adult ,Male ,Parents ,Coping (psychology) ,medicine.medical_specialty ,Waiting Lists ,Pilot Projects ,Article ,Treatment and control groups ,03 medical and health sciences ,0302 clinical medicine ,Adaptation, Psychological ,Developmental and Educational Psychology ,medicine ,Humans ,0501 psychology and cognitive sciences ,Autistic Disorder ,Child ,Virtual Reality Exposure Therapy ,Public health ,05 social sciences ,Pilot trial ,Middle Aged ,medicine.disease ,Distress ,Autism spectrum disorder ,Child, Preschool ,Autism ,Female ,Psychology ,Stress reactivity ,Stress, Psychological ,030217 neurology & neurosurgery ,050104 developmental & child psychology ,Clinical psychology - Abstract
Parents of children with Autism experience high levels of stress. Resiliency is the ability to cope and adapt when faced with stressful events. This randomized, waitlist controlled pilot trial examines the feasibility, acceptability, and preliminary efficacy of an adapted virtual mind–body group intervention for parents of children with ASD. The intervention was feasible and acceptable. The immediate treatment group showed no difference in distress and greater improvement in resiliency and stress reactivity/coping relative to the delayed treatment group, (M difference 5.78; p = .038 and M difference 7.78; p = .001 respectively). Findings showed promising feasibility, acceptability, and preliminary efficacy for parents of children with ASD.
- Published
- 2019
22. Bridge: Person-Centered Collaborative Care for Patients with Serious Mental Illness and Cancer
- Author
-
Andrew A. Nierenberg, Joseph A. Greer, William F. Pirl, Kelly E. Irwin, Amy E. Corveleyn, Elyse R. Park, David P. Ryan, Jennifer S. Temel, Lauren E. Fields, Catherine A. Callaway, Giselle K. Perez, and Jamie M. Jacobs
- Subjects
Male ,Cancer Research ,medicine.medical_specialty ,Psycho-oncology ,Collaborative Care ,Severity of Illness Index ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Informed consent ,Neoplasms ,Patient-Centered Care ,Brief Psychiatric Rating Scale ,medicine ,Humans ,030212 general & internal medicine ,Cooperative Behavior ,business.industry ,Mental Disorders ,Community Outreach ,Cancer ,Middle Aged ,Patient Acceptance of Health Care ,Prognosis ,Mental illness ,medicine.disease ,Mental health ,Self Care ,Oncology ,030220 oncology & carcinogenesis ,Family medicine ,Quality of Life ,Feasibility Studies ,Female ,business ,Follow-Up Studies - Abstract
Background Individuals with serious mental illness (SMI) experience increased cancer mortality due to inequities in cancer treatment. Psychiatric care at cancer diagnosis may improve care delivery, yet models for integrating psychiatry and cancer care are lacking. We assessed the feasibility and acceptability of a person-centered collaborative care trial for SMI and cancer. Subjects, materials, and methods We developed the Bridge intervention for patients with SMI (schizophrenia, bipolar disorder, and severe major depression) and cancer. Bridge includes proactive identification of SMI, person-centered care from a psychiatrist and case manager, and collaboration with oncology. We conducted a 12-week, single-group trial in patients with SMI and a new breast, gastrointestinal, lung, or head/neck cancer. We assessed the feasibility of patient identification, enrollment and study completion; evaluated acceptability and perceived benefit with exit interviews with patients, caregivers, and oncology clinicians; and examined change in psychiatric symptoms with the Brief Psychiatric Rating Scale (BPRS). Results From November 2015 to April 2016, 30/33 eligible patients (90.9%) enrolled, and 25/29 (86.2%) completed assessments at all timepoints, meeting feasibility criteria. Of 24 patients, 23 (95.8%) found meeting with the psychiatrist helpful; 16/19 caregivers (84.2%) shared that Bridge addressed key caregiving challenges. Oncology clinicians evaluated Bridge as "very" or "most" useful for 94.3% of patients. Exit interviews with all participant groups suggested that Bridge fostered patient-clinician trust, increased access to psychiatric treatment, and enabled patients to initiate and complete cancer treatment. Psychiatric symptoms on the BPRS improved from baseline to 12 weeks. Conclusion Bridge is a feasible and acceptable care delivery model for patients with SMI, their caregivers, and oncology clinicians. Randomized trials are warranted to assess the efficacy of improving cancer outcomes in this underserved population. Implications for practice Serious mental illness affects 13 million U.S. adults who experience increased cancer mortality. To improve outcomes, new models of integrated oncology and mental health care are urgently needed. This study found that it was feasible to identify, enroll, and retain patients with serious mental illness and a new cancer in a trial of integrated mental health and cancer care (Bridge). Patients, caregivers, and oncologists reported that Bridge facilitated the initiation and completion of cancer care. Randomized trials are warranted to investigate the impact on cancer outcomes. Trial procedures may inform consent, engagement, and trial retention for patients with mental illness.
- Published
- 2019
23. Randomized Trial of a Tailored Cognitive-Behavioral Therapy Mobile Application for Anxiety in Patients with Incurable Cancer
- Author
-
Charn Xin Fuh, Jennifer S. Temel, Areej El-Jawahri, James J. MacDonald, Joseph A. Greer, Alina Ward, Steven A. Safren, William F. Pirl, Frank J. Penedo, Alona Muzikansky, Colleen Tallen, Jamie M. Jacobs, Giselle K. Perez, Nicole Pensak, and Lara Traeger
- Subjects
Male ,Health Knowledge, Attitudes, Practice ,Cancer Research ,medicine.medical_specialty ,Hamilton Anxiety Rating Scale ,medicine.medical_treatment ,Anxiety ,Patient Health Questionnaire ,Hospital Anxiety and Depression Scale ,Severity of Illness Index ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Patient Education as Topic ,Randomized controlled trial ,Quality of life ,law ,Neoplasms ,medicine ,Humans ,030212 general & internal medicine ,Aged ,Neoplasm Staging ,Cognitive Behavioral Therapy ,business.industry ,Palliative Care ,Middle Aged ,Mobile Applications ,Cognitive behavioral therapy ,Treatment Outcome ,Mood ,Oncology ,Symptom Management and Supportive Care ,030220 oncology & carcinogenesis ,Quality of Life ,Physical therapy ,Clinical Global Impression ,Female ,medicine.symptom ,business - Abstract
Background The aim of this study was to test the efficacy of a tailored cognitive-behavioral therapy (CBT) mobile application (app) to treat anxiety in patients with incurable cancer. Materials and Methods Patients with incurable cancers (n = 145) who reported elevated anxiety symptoms at two cancer centers were randomized to receive either the CBT mobile app for anxiety or a mobile health education program (control) delivered via tablet computers, which patients self-administered over 12 weeks. To assess anxiety, depression symptoms, and quality of life (QOL), we used the Hamilton Anxiety Rating Scale (HAM-A, primary outcome), Clinical Global Impression Scale, Hospital Anxiety and Depression Scale (HADS), Patient Health Questionnaire-9, and Functional Assessment of Cancer Therapy-General at baseline and 12 weeks. Analysis of covariance models were calculated to assess intervention effects on patient outcomes. Results Patients (73.8% female; 91.0% white; mean age = 56.45 years, SD = 11.30) in both study groups reported improvements in anxiety, depression symptoms, and QOL from baseline to postassessment, with no significant differences in any outcome measure between groups. Secondary analyses showed that, among the subgroup of patients with severe baseline anxiety, those randomized to the CBT app had greater improvements on the HAM-A (Mean Difference = 7.44, standard error [SE] = 3.35, p = .037) and HADS-Anxiety Subscale (Mean Difference = 4.44, SE = 1.60, p = .010) compared with the control group. Conclusion Both the tailored CBT app for anxiety and the health education program were associated with improvements in anxiety, mood, and QOL, but these outcomes did not differ between study groups. The CBT app was more beneficial than health education for patients with severe baseline anxiety.
- Published
- 2019
24. Cost-effectiveness of Implementing Smoking Cessation Interventions for Patients With Cancer
- Author
-
Douglas E, Levy, Susan, Regan, Giselle K, Perez, Alona, Muzikansky, Emily R, Friedman, Julia, Rabin, Nancy A, Rigotti, Jamie S, Ostroff, and Elyse R, Park
- Subjects
Behavior Therapy ,Cost-Benefit Analysis ,Neoplasms ,Smoking ,Humans ,Smoking Cessation ,General Medicine - Abstract
Guidelines recommend cancer care clinicians offer smoking cessation treatment. Cost analyses will help stakeholders understand and plan for implementation of cessation programs.To estimate the incremental cost per quit (ICQ) of adopting an intensive smoking cessation intervention among patients undergoing treatment at cancer care clinics, from a clinic perspective.This economic evaluation, a secondary analysis of the Smokefree Support Study (conducted 2013-2018; completed 2021), used microcosting methods and sensitivity analyses to estimate the ICQ of the interventions. Participants included patients undergoing treatment for a broad range of solid tumors and lymphomas who reported current smoking and were receiving care at cancer care clinics within 2 academic medical centers.Intensive smoking cessation treatment (up to 11 counseling sessions with free medications), standard of care (up to 4 counseling sessions with medication advice), or usual care (referral to the state quitline).Total costs, component-specific costs, and the ICQ of the intensive smoking cessation treatment relative to both standard of care (comparator in the parent randomized trial) and usual care (a common comparator outside this trial) were calculated. Overall and post hoc site-specific estimates are provided. Because usual care was not included in the parent trial, sensitivity analyses were conducted to assess how assumptions about usual care quit rates affected study outcomes (ie, base case [from a published smoking cessation trial among patients with thoracic cancer], best case, and conservative case scenarios).The per-patient costs of offering intensive smoking cessation treatment, standard of care, and usual care were $1989, $1482, and $0, respectively. For intensive treatment, the dominant costs were treatment (35%), staff supervision (26%), and patient enrollment (24%). Relative to standard of care, intensive treatment had an overall ICQ of $3906, and one site had an ICQ of $2892. Relative to usual care, intensive treatment had an ICQ of $9866 overall (base case), although at one site, the ICQ was $5408 (base case) and $3786 (best case).In this economic evaluation study, implementation of an intensive smoking cessation treatment intervention was moderately to highly cost-effective, depending on existing smoking cessation services in place.
- Published
- 2022
25. A Comprehensive Resiliency Framework: Theoretical Model, Treatment, and Evaluation
- Author
-
Brett M. Goshe, Suzanne C. Lechner, Elyse R. Park, Christina M. Luberto, Ana-Maria Vranceanu, John W. Denninger, Lara Traeger, Gregory L. Fricchione, Daniel L. Hall, Herbert Benson, Emma Chad-Friedman, Giselle K. Perez, and Margaret Baim
- Subjects
Medicine (General) ,03 medical and health sciences ,R5-920 ,0302 clinical medicine ,Risk analysis (engineering) ,Computer science ,Measure (physics) ,Original Article ,General Medicine ,Public aspects of medicine ,RA1-1270 ,030217 neurology & neurosurgery ,030227 psychiatry - Abstract
BackgroundThere is heterogeneity in conceptualizations of resiliency, and there is, to date, no established theoretically driven resiliency assessment measure that aligns with a targeted resiliency intervention. We operationalize resiliency as one’s ability to maintain adaptive functioning in response to the ongoing, chronic stress of daily living, and we use a novel resiliency measure that assesses the target components of an evidence based resiliency intervention. We present our resiliency theory, treatment model, and corresponding assessment measure (Current Experience Scale; CES).MethodsTo establish the psychometric properties of the CES, we report the factor structure and internal consistency reliability (N = 273). Among participants in our resiliency intervention (N = 151), we explored construct validity in terms of associations with theoretical model constructs, a validated resiliency measure, and sensitivity to change from before to after the intervention.ResultsResults indicated that a 23-item, 6-factor solution was a good fit to the data (RMSEA = .08, CFI = .97; TLI =.96) and internal consistency was good (α = .81 to .95). The CES showed correlations in the expected direction with resiliency model constructs (all p’s ConclusionOur resiliency theory, treatment model, and outcome appear aligned; the CES demonstrated promise as a psychometrically sound outcome measure for our resiliency intervention and may be used in future longitudinal studies and resiliency building interventions to assess individuals’ resiliency to adapt to ongoing stress.
- Published
- 2021
26. Launching a resiliency group program to assist frontline clinicians in meeting the challenges of the COVID-19 pandemic: Results of a hospital-based systems trial
- Author
-
Elyse R. Park, Nevita George, Joanna M. Streck, Giselle K. Perez, Stacie Fredriksson, Rachel Vanderkruik, Christina M. Luberto, Rachel A. Millstein, Louisa G. Sylvia, Helen Mizrach, Laura Malloy, Gregory L. Fricchione, Sydney Crute, Cayley C. Bliss, Sara E. Looby, Karen Donelan, Mary Susan Convery, Christine Vogeli, Darshan H. Mehta, Betsy Remington Hart, A. Clare Stupinski, John W. Denninger, Ellen A. Slawsby, Lara Traeger, Daniel L. Hall, Amelia M. Stanton, April Hirschberg, Sabine Wilhelm, John B. Herman, Jocelyn Meek, Margaret Baim, Maurizio Fava, Michelle L. Dossett, Daphne J. Holt, and Katherine C. Rosa
- Subjects
Adult ,Male ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,media_common.quotation_subject ,MEDLINE ,Hospitals, General ,Occupational Stress ,Nursing ,Pandemic ,Humans ,Group program ,Program Development ,Letter to the Editor ,media_common ,COVID-19 ,Hospital based ,Middle Aged ,Resilience, Psychological ,Telemedicine ,Personnel, Hospital ,Psychotherapy ,Psychiatry and Mental health ,Program development ,Female ,Psychological resilience ,Psychology - Published
- 2021
- Full Text
- View/download PDF
27. Responding to COVID-19 Stress: Disseminating Mind-Body Resiliency Approaches
- Author
-
Giselle K. Perez, Daniel L. Hall, Rachel A. Millstein, Elyse R. Park, and Christina M. Luberto
- Subjects
Stress management ,stress management ,Applied psychology ,Psychological intervention ,050109 social psychology ,03 medical and health sciences ,0302 clinical medicine ,Intervention (counseling) ,View Point ,Pandemic ,Health care ,0501 psychology and cognitive sciences ,030212 general & internal medicine ,intervention ,lcsh:R5-920 ,business.industry ,lcsh:Public aspects of medicine ,05 social sciences ,Stressor ,lcsh:RA1-1270 ,resiliency ,General Medicine ,Variety (cybernetics) ,healthcare clinicians ,mind-body ,lcsh:Medicine (General) ,Psychology ,business ,Psychosocial - Abstract
The COVID-19 pandemic has resulted in unprecedented stress and uncertainty, particularly among vulnerable populations such as healthcare workers who are facing a multitude of current and looming economic and psychosocial stressors. As clinician-scientists delivering mind-body interventions in our hospital, we suggest applying evidence-based mind-body techniques that promote resiliency and adaptive coping during these difficult times. Interventions that package a variety of mind-body skills into one cohesive program, such as the Stress Management and Resiliency Training – Relaxation Response Resiliency Program (SMART-3RP), offer promise for meeting the variety of stress management needs (e.g., health concerns, isolation) present during the COVID-19 pandemic. From our work with frontline healthcare clinicians and other caregiver populations, we offer recommendations for adapting the delivery, modality, and content of mind-body practices during the COVID-19 pandemic and suggest key skills for promoting resiliency and buffering against the future stressors that lie ahead for everyone.
- Published
- 2020
28. A virtual resiliency program for lymphoma survivors: helping survivors cope with post-treatment challenges
- Author
-
Jeremy S. Abramson, Giselle K. Perez, Emily A. Walsh, Elyse R. Park, and Kit M. Quain
- Subjects
Gerontology ,Stress management ,Lymphoma ,media_common.quotation_subject ,Public Health, Environmental and Occupational Health ,Pilot Projects ,General Medicine ,General Chemistry ,Telehealth ,Anxiety ,Article ,Test (assessment) ,Survivorship curve ,Adaptation, Psychological ,Quality of Life ,Humans ,Group program ,Psychological resilience ,Survivors ,Post treatment ,Psychology ,Applied Psychology ,media_common - Abstract
OBJECTIVES: To adapt and test the feasibility, acceptability, and preliminary efficacy of an 8-week resiliency group program for posttreatment lymphoma survivors. DESIGN AND OUTCOMES. This is an exploratory mixed methods study. Phase 1: We conducted qualitative interviews to inform program adaptation. Phase 2: Using a single-arm pilot design, we assessed program feasibility, acceptability, and preliminary efficacy (exploratory outcomes: stress coping, uncertainty intolerance, distress). We also examined the feasibility of collecting hair cortisol samples. RESULTS. Phase 1: Survivors reported feeling socially isolated as they grappled with lingering symptoms that interfered with their return to normalcy. Fears about recurrence triggered bodily hypervigilance. Survivors desired wellness programs that 1) target their whole-body experience, 2) promote social connectedness, and 3) manage fear of recurrence. Phase 2: Thirty-seven survivors enrolled. Participants completed a median of 7/8 sessions, and 76.9% completed ≥6/8 sessions; 65% provided a hair sample. Survivors demonstrated improvements in stress coping (d=.67), uncertainty tolerance (d=.71), and anxiety (d=.41) at program completion. CONCLUSIONS. Findings suggest promising feasibility and efficacy of this program in addressing posttreatment survivorship challenges, particularly fears of uncertainty. A cancer care model that adopts early integration of this program posttreatment has the potential to improve survivors’ emotional, social and physical well-being.
- Published
- 2020
29. An Exploration of Health Behaviors in a Mind-Body Resilience Intervention for Parents of Children with Developmental Disabilities
- Author
-
Giselle K. Perez, Karen Kuhlthau, Rachel A. Millstein, Christina M. Luberto, Gabrielle N Schwartz, Olivia J. Lindly, and Elyse R. Park
- Subjects
Adult ,Male ,Parents ,Stress management ,Autism Spectrum Disorder ,media_common.quotation_subject ,Developmental Disabilities ,Population ,Health Behavior ,Special needs ,Pilot Projects ,Article ,03 medical and health sciences ,0302 clinical medicine ,030225 pediatrics ,Intervention (counseling) ,Developmental and Educational Psychology ,medicine ,Humans ,0501 psychology and cognitive sciences ,education ,Child ,media_common ,education.field_of_study ,Descriptive statistics ,Learning Disabilities ,Mind-Body Therapies ,05 social sciences ,Secondary data ,Middle Aged ,Resilience, Psychological ,medicine.disease ,Psychiatry and Mental health ,Autism spectrum disorder ,Attention Deficit Disorder with Hyperactivity ,Neurodevelopmental Disorders ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Female ,Psychological resilience ,Psychology ,Internet-Based Intervention ,050104 developmental & child psychology ,Clinical psychology - Abstract
Objective Parents of children with special needs such as learning and attentional disabilities (LADs) and autism spectrum disorder (ASD) are at high risk for stress-related disorders. The demands of parenting may compete with time for self-care behaviors such as physical activity, healthy eating, and adequate sleep. The objective was to describe health behaviors among this understudied population and assess the changes after a resilience intervention. Methods This was a secondary data analysis of a randomized controlled pilot virtual mind-body resilience intervention (Stress Management and Resiliency Training: A Relaxation Response Resiliency Program) trial for parents of children with LADs (n = 52) and ASD (n = 47). Parents completed self-report questionnaires about their weekly physical activity, eating behaviors, sleep duration, and fatigue before and after the 8-week intervention. Descriptive statistics and pre-post intervention effect sizes (Cohen's d) were calculated. Results Both parent groups reported suboptimal levels of health behaviors at baseline, but ASD parents reported lower health behaviors than LAD parents. LAD parents improved more on physical activity, with a higher percentage meeting recommendations at postintervention follow-up (d = 0.71) than ASD parents (d = 0.01). Eating behaviors showed small effect size improvements for both groups. Although sleep duration improved only with small or medium effect sizes for both groups, ASD parents rated their fatigue lower after the intervention (d = 0.81). Conclusion Parents of children with special needs who participated in a virtual resilience intervention demonstrated suboptimal health behaviors. There is a need for targeted interventions for health behaviors that can promote resilience in these high-stress populations.
- Published
- 2020
30. Barriers and strategies for implementing community-based interventions with minority elders: positive minds-strong bodies
- Author
-
Paola del Cueto, Giselle K. Perez, Sheri Lapatin Markle, Amanda NeMoyer, Margarita Alegría, Larimar Fuentes, and Thalia Porteny
- Subjects
Medicine (General) ,Physical disability ,Minority group ,Racial/ethnic minority elders ,Population ,Psychological intervention ,Anxiety ,CHW ,Health administration ,03 medical and health sciences ,R5-920 ,0302 clinical medicine ,Nursing ,Immigrants ,0501 psychology and cognitive sciences ,030212 general & internal medicine ,education ,Health policy ,education.field_of_study ,Disability ,Depression ,Research ,05 social sciences ,Health services research ,Focus group ,Psychology ,050104 developmental & child psychology - Abstract
Background By 2040, one out of three older adults in the USA are expected to belong to a racial/ethnic minority group. This population has an increased risk of mental and physical disability with significant barriers to access care. Community-based organizations (CBOs) often provide programming to serve minority and immigrant elders. Limited resources and other barriers such as lack of trained staff make it difficult to implement evidence-based interventions (EBIs) in CBOs for long-term adoption. Yet little is known about what factors can facilitate adoption of EBIs in CBOs serving minority elders. Methods Positive-Minds–Strong Bodies (PM-SB), an evidence-based intervention offered in four languages, aims to reduce mental and physical disability for minority and immigrant elders through the efforts of community health workers and exercise trainers. The intervention consists of cognitive behavior therapy and exercise training sessions delivered over 6 months. During a recent clinical trial of this intervention, we elicited feedback from CBO staff to determine how best to facilitate the implementation and long-term sustainability of PM-SB within their agencies. We surveyed 30 CBO staff members, held four focus groups, and conducted 20 in-depth interviews to examine staff perspectives and to reveal factors or changes needed to facilitate long-term adoption in prospective CBOs. Results Participants reported that staff motivation and implementation could be improved through the following changes: increasing patient compensation for treatment sessions, decreasing levels of organizational accountability, and reducing staff demands embedded in the intervention. Although most staff perceived that PM-SB improved their agency’s ability to address the health and well-being of elders, capacity-building strategies such as a “train-the-trainer” initiative were identified as priorities to address staff turnover for sustainability. Adapting the intervention to get financial reimbursement also emerged as vital. Conclusions Augmenting financial incentives, streamlining procedures, and simplifying staff accountability were suggested strategies for facilitating the transition from a disability prevention clinical trial in minority and immigrant elders to a scalable implementation in routine services at CBOs. Trial registration ClinicalTrials.gov, NCT02317432.
- Published
- 2020
31. Taboo Topics in Adolescent and Young Adult Oncology: Strategies for Managing Challenging but Important Conversations Central to Adolescent and Young Adult Cancer Survivorship
- Author
-
John M. Salsman, Abby R. Rosenberg, Anne C. Kirchhoff, Kaitlyn Fladeboe, Elyse R. Park, and Giselle K. Perez
- Subjects
Oncology ,Adult ,Male ,medicine.medical_specialty ,Referral ,Adolescent ,Article ,03 medical and health sciences ,Social support ,Young Adult ,0302 clinical medicine ,Quality of life (healthcare) ,Cancer Survivors ,030225 pediatrics ,Internal medicine ,Survivorship curve ,Neoplasms ,Health care ,medicine ,Humans ,Young adult ,Reproductive health ,business.industry ,Communication ,Social Support ,General Medicine ,humanities ,030220 oncology & carcinogenesis ,Quality of Life ,Female ,Psychology ,business ,Psychosocial - Abstract
Research on adolescents and young adults (AYAs) with cancer has flourished over the past decade, underscoring the unique medical and psychosocial needs of this vulnerable group. A cancer diagnosis during adolescence and young adulthood intersects with the developmental trajectory of AYAs, derailing critical physical, social, and emotional development. AYAs face these abrupt life changes needing age-appropriate information and resources to offset these challenges. Greater attention is needed to address AYA-specific concerns on reproductive and sexual health, financial security and independence, emotional well-being, social support, and end-of-life care. If these unique needs are unaddressed, this can adversely affect AYAs’ health care engagement and overall quality of life, increasing their risk for cancer-related morbidity and early mortality. In particular, health care decisions made during treatment have important implications for AYA patients’ future health. Oncology clinicians are well positioned to address AYA patients’ concerns by anticipating and addressing the challenges this age group is likely to face. In this paper, we explore several core topics that affect AYAs’ quality of life and that can be challenging to address. Starting from the moment of diagnosis, through cancer treatment and post-treatment survivorship, and into end of life, each section highlights critical developmental-centric life domains that are affected by the cancer experience. Specifically, we discuss resources, tools, and strategies to navigate these challenging conversations. Taking a risk-reduction approach that invites two-way communication and facilitates referral to age-appropriate resources would help destigmatize these experiences and, in turn, would support the provision of compassionate and effective age-concordant care to this vulnerable group.
- Published
- 2020
32. Mental health insurance access and utilization among childhood cancer survivors: a report from the childhood cancer survivor study
- Author
-
Christopher J. Recklitis, Karen Kuhlthau, Kevin R. Krull, Gregory T. Armstrong, Elyse R. Park, Giselle K. Perez, Wendy M. Leisenring, Julia Rabin, Anne C. Kirchhoff, Leslie L. Robison, and Paul C. Nathan
- Subjects
Adult ,Male ,Mental Health Services ,Gerontology ,medicine.medical_specialty ,Childhood Cancer Survivor Study ,Health informatics ,Article ,Health Services Accessibility ,Insurance Coverage ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Cancer Survivors ,Neoplasms ,Surveys and Questionnaires ,Survivorship curve ,Humans ,Medicine ,Longitudinal Studies ,030212 general & internal medicine ,Age of Onset ,Child ,Retrospective Studies ,Medically Uninsured ,Insurance, Health ,Oncology (nursing) ,business.industry ,Siblings ,Public health ,social sciences ,Middle Aged ,Patient Acceptance of Health Care ,Pediatric cancer ,Mental health ,humanities ,Distress ,Cross-Sectional Studies ,Oncology ,030220 oncology & carcinogenesis ,population characteristics ,Female ,business ,human activities ,Stress, Psychological ,Patient education - Abstract
PURPOSE: To describe and compare the prevalence of mental health access, preference, and use among pediatric cancer survivors and their siblings. To identify factors associated with mental health access and use among survivors. METHODS: 698 survivors in the Childhood Cancer Survivor Study (median age=39.4; median years from diagnosis=30.8) and 210 siblings (median age=40.4) were surveyed. Outcomes included having mental health insurance coverage, delaying care due to cost, perceived value of mental health benefits, and visiting a mental health provider in the past year. RESULTS: There were no differences in mental health access, preferences, and use between survivors and siblings (p>0.05). Among respondents with a history of distress, most reported not having seen a mental health provider in the past year (80.9% survivors vs. 77.1% siblings; p=0.60). Uninsured survivors were more likely to defer mental health services due to cost (24.6% vs. 8.4%; p
- Published
- 2018
33. Examining the effects of stress and psychological distress on smoking abstinence in cancer patients
- Author
-
Adam Gonzalez, Nancy A. Rigotti, Christina M. Luberto, Joanna M. Streck, Colin Ponzani, Daniel L. Hall, Jamie S. Ostroff, Alona Muzikansky, Elyse R. Park, Sarah Skurla, Giselle K. Perez, and Brittain Mahaffey
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,media_common.quotation_subject ,030209 endocrinology & metabolism ,Health Informatics ,Smoking cessation ,Anxiety ,Stress ,Logistic regression ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Internal medicine ,medicine ,030212 general & internal medicine ,media_common ,business.industry ,Standard treatment ,Distress ,Public Health, Environmental and Occupational Health ,Cancer ,Regular Article ,Cancer patients ,Abstinence ,medicine.disease ,Medicine ,Smoking cessation intervention ,medicine.symptom ,business - Abstract
Highlights • We explored stress, distress, and smoking in a cessation trial for cancer patients. • Patients reported decreases in stress and distress over time in both study groups. • Anxiety negatively impacted smoking cessation success at 6-mo follow-up., Introduction Cancer patients who smoke report more stress and psychological distress than patients who do not smoke. It is unclear how these emotional symptoms may modify smoking behavior in cancer patients. We examined the influence of a smoking cessation intervention for cancer patients on stress and distress, and the effects of these symptoms on smoking abstinence. Methods Mixed-methods secondary analysis of data from the Smokefree Support Study, a two-site randomized controlled trial examining the efficacy of Intensive (IT; n = 153) vs. Standard Treatment (ST; n = 150) for smoking cessation in newly diagnosed cancer patients. Stress coping, perceived stress, distress, and anxiety were self-reported at baseline, 3, and 6 months. Abstinence was biochemically-confirmed at 6 months. A subset of patients (n = 72) completed qualitative exit-interviews. Results Patients were on average, 58 years old, 56% female, and smoked a median of 10 cigarettes/day. There were no significant treatment group × time interactions or main effects of treatment group on stress or distress measures (p’s > 0.05), however there were significant main effects of time suggesting symptom improvements on each measure in both study groups (p’s
- Published
- 2021
34. Patient-Reported Outcomes Among Patients with High-Risk Untreated Follicular Lymphoma (FL) Randomized to Bendamustine/Rituximab (BR) or Bendamustine/Rituximab with Bortezomib (BVR) Therapy: Results from the ECOG-ACRIN E2408 Study
- Author
-
Thomas M. Habermann, Giselle K. Perez, Andrew M. Evens, Puneet Cheema, Jane N. Winter, Fangxin Hong, Philip A. Dy, Lynne I. Wagner, Stephen M. Ansell, Timothy E. O'Brien, Brad S. Kahl, Ranjana H. Advani, David Cella, and Julie E. Chang
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Bortezomib ,Immunology ,Follicular lymphoma ,Cell Biology ,Hematology ,Bendamustine/rituximab ,medicine.disease ,Biochemistry ,Internal medicine ,Medicine ,business ,medicine.drug - Abstract
Introduction: FL is the most common indolent non-Hodgkin lymphoma in the Western world. FL may cause disease-related symptoms, and patients with high-risk disease usually require systemic therapy. BR is commonly used as first-line therapy for high-risk FL, and the addition of bortezomib to a BR backbone has been studied (Evens A et al. Clin Can Res 2020). Little is known about how these therapeutic options impact patients' health-related quality of life (HRQL). To fill this gap, patient-reported outcomes (PROs) were administered to patients enrolled on E2408 to quantify symptom burden and effects of BR versus BVR induction on HRQL. Methods: Patients (n=258) randomized to receive 6 cycles of BR or BVR induction completed PROs assessing neurotoxicity (FACT/GOG-Ntx) at the beginning of each treatment cycle. Additional PROs measuring fatigue (FACT-F), lymphoma-specific concerns (FACT-Lym) and HRQL (Functional Assessment of Cancer Therapy-General; FACT-G) were completed at baseline, mid-treatment (MT; cycle 3/4) and end of induction (EOI; cycle 6). Paired t-test was used to assess PRO score changes from baseline to MT and EOI within BR or BVR group. Two-sample t-test was used to compare change scores between groups at MT and EOI, respectively. Univariate analyses with a linear model identified patient baseline characteristics and clinical factors (age, sex, stage, performance status, # extra nodal sites, FLIPI, GELF, bone marrow involvement, elevated LDH, palpable splenomegaly, B-symptoms, CRIS) associated with PRO change scores from baseline to EOI, adjusting for treatment group. A multivariate model was built with backward variable selection approach for each of the PROs. Results: As shown in Figure 1, compared with baseline, patients randomized to BVR reported significantly worse FACT/GOG-Ntx scores at cycle 4, which continued to end of induction (FACT/GOG-Ntx change scores -2.91 to -3.73; p < 0.001). Neurotoxicity remained stable for patients treated with BR (Ntx change scores -0.02 to -0.55). FACT-Fatigue scores indicated worse fatigue at MT compared to baseline for patients receiving BVR (-2.7, p Univariate analyses among all patients identified older age and the absence of palpable splenomegaly at baseline as associated with worse FACT-Lym, FACT-Fatigue, and FACT-G change scores, signifying less improvement in lymphoma-related symptoms, fatigue and HRQL from baseline to end of induction (p Conclusions: Despite worse treatment-related symptoms throughout induction, the addition of bortezomib was associated with comparable overall HRQL to those treated with BR. Both treatments were associated with a reduction in lymphoma-related symptoms from baseline to end of induction, likely contributing to stable HRQL throughout treatment despite treatment-related symptoms. Findings also suggest that a subgroup of patients, particularly those who are older, may experience fewer improvements in lymphoma-related symptoms. This underscores the potential need for closer monitoring and clinical management of these patients. Collectively, results are likely to be encouraging for patients experiencing lymphoma-related symptoms, for whom the symptom burden associated with treatment may be worth the trade-off given the potential for improved disease-related symptom control. Disclosures Evens: Merck: Consultancy, Honoraria, Research Funding; Seattle Genetics: Consultancy, Honoraria, Research Funding; Abbvie: Consultancy, Honoraria; Pharmacyclics: Consultancy, Honoraria; MorphoSys: Consultancy, Honoraria; Research To Practice: Honoraria, Speakers Bureau; Epizyme: Consultancy, Honoraria, Research Funding; Mylteni: Consultancy, Honoraria; Novartis: Consultancy, Honoraria. Advani:Celgene, Forty Seven, Inc., Genentech/Roche, Janssen Pharmaceutical, Kura, Merck, Millenium, Pharmacyclics, Regeneron, Seattle Genetics: Research Funding; Astra Zeneca, Bayer Healthcare Pharmaceuticals, Cell Medica, Celgene, Genentech/Roche, Gilead, KitePharma, Kyowa, Portola Pharmaceuticals, Sanofi, Seattle Genetics, Takeda: Consultancy. Ansell:Trillium: Research Funding; Affimed: Research Funding; Regeneron: Research Funding; AI Therapeutics: Research Funding; Takeda: Research Funding; Seattle Genetics: Research Funding; Bristol Myers Squibb: Research Funding; ADC Therapeutics: Research Funding. Winter:Norvartis: Consultancy, Other: DSMB; Ariad/Takeda: Consultancy; CVS/Caremark: Consultancy; Delta Fly Pharma: Consultancy; Amgen: Consultancy; Epizyme: Other: DSMB; Merck: Membership on an entity's Board of Directors or advisory committees, Other: advisory board; Karyopharm: Membership on an entity's Board of Directors or advisory committees, Other: advisory board. Cella:FACIT.org: Membership on an entity's Board of Directors or advisory committees, Other: President; Astellas: Consultancy, Honoraria; Pled Pharma: Research Funding; Janssen: Research Funding; Clovis: Research Funding; Alexion: Research Funding; Apellis: Consultancy; Pfizer: Consultancy, Research Funding; Novartis: Consultancy; Kiniksa: Consultancy; IDDI: Consultancy; BMS: Consultancy, Research Funding; ASAHI KASEI PHARMA CORP.: Consultancy; Oncoquest: Consultancy; Mei Pharma: Consultancy; Ipsen: Consultancy, Research Funding; Evidera: Consultancy; DSI: Consultancy, Research Funding; BlueNote: Consultancy; Abbvie: Consultancy, Research Funding; PROMIS Health Org: Membership on an entity's Board of Directors or advisory committees, Other. Kahl:ADC Therapeutics: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Janssen: Consultancy, Membership on an entity's Board of Directors or advisory committees; BeiGene: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Roche Laboratories Inc: Consultancy; Pharmacyclics LLC: Consultancy; Genentech: Consultancy; Celgene Corporation: Consultancy; AstraZeneca Pharmaceuticals LP: Consultancy, Membership on an entity's Board of Directors or advisory committees; AbbVie: Consultancy; Acerta: Consultancy, Research Funding. Wagner:Celgene Inc.: Membership on an entity's Board of Directors or advisory committees; Connect Multiple Myeloma Registry: Membership on an entity's Board of Directors or advisory committees.
- Published
- 2020
35. A Virtual Resiliency Intervention Promoting Resiliency for Parents of Children with Learning and Attentional Disabilities: A Randomized Pilot Trial
- Author
-
Christina M. Luberto, Lara Traeger, Emma Chad-Friedman, Giselle K. Perez, Jacqueline Proszynski, Rachel A. Millstein, Elyse R. Park, and Karen Kuhlthau
- Subjects
Male ,Parents ,Stress management ,Epidemiology ,law.invention ,03 medical and health sciences ,Social support ,0302 clinical medicine ,Randomized controlled trial ,law ,030225 pediatrics ,Intervention (counseling) ,Intellectual Disability ,Outcome Assessment, Health Care ,Medicine ,Humans ,Family ,Child ,030219 obstetrics & reproductive medicine ,business.industry ,Depression ,Stressor ,Public Health, Environmental and Occupational Health ,Obstetrics and Gynecology ,Middle Aged ,Patient Acceptance of Health Care ,Resilience, Psychological ,Focus group ,Disabled Children ,Distress ,Meditation ,Attention Deficit Disorder with Hyperactivity ,Pediatrics, Perinatology and Child Health ,Psychotherapy, Group ,Quality of Life ,Anxiety ,Feasibility Studies ,Female ,medicine.symptom ,business ,Stress, Psychological ,Clinical psychology ,Program Evaluation - Abstract
One in five children have a learning and attentional disability (LAD). Parents of children with LAD are vulnerable to distress, but an evidence-based treatment has not been developed. From June 2016 to November 2017, we conducted a mixed methods study to adapt and assess the virtual delivery of a mind-body group resiliency program, the Stress Management and Resiliency Training-Relaxation Response Resiliency Program (SMART-3RP), to meet the needs of parents of children with LAD; this is an 8-session weekly group intervention. In the first phase, we conducted 4 parent focus group interviews, 2 professional focus group interviews, and 5 professional individual interviews, and 1 pilot group to adapt the SMART-3RP to target the needs of parents of children with LAD. In the second phase, we conducted a pilot wait-list controlled study to assess the feasibility, acceptability, and preliminary efficacy of a videoconferencing delivery of the adapted program. Parents were randomized to an immediate intervention group (IG) or wait-list control group (WC). Surveys were administered at baseline (time 1), end of intervention for the IG or 3 months post-baseline for the WC (time 2), and 3 months post treatment for the IG or end of intervention for the WC (time 3). Qualitative findings illustrated high levels of parental stress, with primary stressors including navigating the educational system, interactions with other parents, familial concerns, and financial and professional sacrifices. We adapted the manual to target these stressors and modified session logistics and delivery. Fifty-three parents (mean age = 46.8; 90.6% female) participated nationally in the pilot trial. 62.5% of participants completed ≥ 6/8 sessions; 81.8% reported continued daily/weekly relaxation response exercise practice. T1–T2 comparisons found that IG versus WC participants showed significant improvements in distress [VAS], ∆M = − 1.95; d = .83 and resilience [CES], ∆M = 6.38; d = .83, as well as stress coping [MOCS-A] ∆M = 8.69; d = 1.39; depression and anxiety [PHQ-4], ∆M = − 1.79; d = .71; social support [MOS-SSS], ∆M = 5.47; d = .71; and empathy [IRI], ∆M = 3.17; d = .77; improvements were sustained at the 3 month post intervention follow-up. Pilot wait-list randomized trial findings showed promising feasibility, acceptability, and preliminary efficacy for the SMART-3RP intervention adapted for parents of children with LAD. This virtually-delivered resiliency intervention improved parents’ distress, resiliency, and stress coping, which were sustained. NCT02772432.
- Published
- 2019
36. Moving forward on all fronts: impact, patterns, and barriers to exercise in cancer survivors and patients living with advanced disease
- Author
-
Sasha E, Knowlton, Elizabeth K, O'Donnell, Nora, Horick, Giselle K, Perez, Elyse, Park, Julia, Rabin, Kit M, Quain, Jessica, Garton, and Jeffrey M, Peppercorn
- Subjects
Male ,Health Services Needs and Demand ,Palliative Care ,Psychosocial Support Systems ,Middle Aged ,Habits ,Cross-Sectional Studies ,Cancer Survivors ,Neoplasms ,Surveys and Questionnaires ,Humans ,Female ,Exercise ,Needs Assessment ,Aged - Abstract
Exercise is recommended for all patients with cancer, but there has been limited study of exercise habits in patients across the spectrum of illness.This pragmatic survey aimed to identify the unmet supportive care needs, self-reported symptoms, and exercise habits among both cancer survivors and patients living with advanced disease to determine adherence to exercise guidelines and to identify barriers and opportunities to improve exercise.An anonymous cross-sectional self-administered paper survey was distributed to patients with cancer presenting for oncology clinic visits at an academic cancer center. Survey measures included presence of symptoms and health problems in addition to weekly time spent exercising, change in exercise levels since diagnosis, interest in exercise, and self-reported barriers. Participants reporting at least 150 min of exercise per week were characterized as adherent to guidelines.Among 640 survey respondents, 570 (89%) completed questions about exercise. Only 44% of cancer survivors and 34% of patients living with advanced disease met current guidelines. Survivors who met exercise guidelines had a lower prevalence of fatigue and memory impairments, but this finding was not seen among patients with advanced cancer. Over 70% of patients with advanced disease and 47% of survivors reported decreasing exercise post-diagnosis compared to pre-diagnosis. Prominent barriers to exercise among both groups included burden of illness and time constraints but interest in increasing exercise was high.There is an opportunity to improve exercise and related outcomes among a large percentage of both cancer survivors and patients living with advanced disease.
- Published
- 2019
37. Fear of Cancer Recurrence: A Model Examination of Physical Symptoms, Emotional Distress, and Health Behavior Change
- Author
-
Katharine Quain, Julia Rabin, Elyse R. Park, Gloria Y. Yeh, Giselle K. Perez, Rachel B. Jimenez, Jeffrey Peppercorn, and Daniel L. Hall
- Subjects
Male ,Emotions ,Health Behavior ,Psychological Distress ,Cancer recurrence ,ORIGINAL CONTRIBUTIONS ,03 medical and health sciences ,0302 clinical medicine ,Quality of life (healthcare) ,Public health surveillance ,Cancer Survivors ,Emotional distress ,Neoplasms ,Medicine ,Humans ,Public Health Surveillance ,030212 general & internal medicine ,Oncology (nursing) ,business.industry ,Health Policy ,Behavior change ,Cancer ,Fear ,medicine.disease ,Mental health ,Mental Health ,Oncology ,Socioeconomic Factors ,030220 oncology & carcinogenesis ,Quality of Life ,Female ,Health behavior ,Neoplasm Recurrence, Local ,business ,Stress, Psychological ,Clinical psychology - Abstract
PURPOSE: Fear of cancer recurrence is highly prevalent among adult survivors of cancer. The role of fear of recurrence in the emotional distress of survivors of cancer, as well as health behaviors that may directly affect their health, remains unclear. To advance oncology practice, this study sought to examine the extent to which fear of recurrence stemming from physical symptoms accounts for emotional distress in a large sample of adult survivors of cancer and to extend the model to explain postdiagnosis self-reported health behavior change. METHODS: In 2016, 258 survivors of cancer at an academic hospital completed a survey of psychosocial needs. Items assessed physical symptoms (checklist), fear of cancer recurrence (Assessment of Survivor Concerns), emotional distress (anxiety and depressed mood), and health behaviors (current alcohol use, physical activity, diet, and sunscreen use, as well as changes after cancer diagnosis) informed by National Comprehensive Cancer Network survivorship guidelines. Indirect effects regression models accounting for relevant covariates (age and treatment history) used 5,000-iteration bootstrapping. RESULTS: Higher fear of cancer recurrence was associated with greater number of physical symptoms ( P < .001), greater emotional distress ( P < .05), lower moderate or vigorous physical activity ( P < .05), higher sunscreen use ( P < .05), and postdiagnosis increases in alcohol use ( P < .01) and reductions in physical activity ( P < .01). Fear of cancer recurrence models accounted for almost half of the variance in distress of survivors of cancer ( R2 = 0.44, P < .001) and, to a lesser yet significant extent, changes in alcohol consumption ( R2 = 0.09, P < .001) and physical activity ( R2 = 0.06, P = .003). CONCLUSION: Fear of cancer recurrence plays a central role in the emotional distress and key health behaviors of survivors of cancer. These findings support fear of cancer recurrence as a potential target for emotional health and health behavior change interventions.
- Published
- 2019
38. Leveraging Positive Psychology to Support Smoking Cessation in Nondaily Smokers Using a Smartphone App: Feasibility and Acceptability Study
- Author
-
John F. Kelly, Eric Helmuth, Christopher W. Kahler, Bettina B. Hoeppner, Susanne S. Hoeppner, Hannah A. Carlon, and Giselle K. Perez
- Subjects
Adult ,Male ,medicine.medical_specialty ,020205 medical informatics ,medicine.medical_treatment ,media_common.quotation_subject ,Psychological intervention ,Pilot Projects ,Health Informatics ,02 engineering and technology ,Information technology ,smartphone ,03 medical and health sciences ,Social support ,0302 clinical medicine ,0202 electrical engineering, electronic engineering, information engineering ,medicine ,Humans ,happiness ,Prospective Studies ,030212 general & internal medicine ,mHealth ,media_common ,Original Paper ,Smokers ,business.industry ,Behavior change ,Social Support ,Middle Aged ,Abstinence ,T58.5-58.64 ,Mobile Applications ,Psychology, Positive ,smoking cessation ,Physical therapy ,Happiness ,Feasibility Studies ,Smoking cessation ,Female ,Self Report ,Positive psychology ,Public aspects of medicine ,RA1-1270 ,business ,cigarettes - Abstract
BackgroundNondaily smoking is an increasingly prevalent smoking pattern that poses substantial health risks. ObjectiveWe tested the feasibility of using a smartphone app with positive psychology exercises to support smoking cessation in nondaily smokers. MethodsIn this prospective, single-group pilot study, nondaily smokers (n=30) used version 1 of the Smiling Instead of Smoking (SiS) app for 3 weeks while undergoing a quit attempt. The app assigned daily happiness exercises, provided smoking cessation tools, and made smoking cessation information available. Participants answered surveys at baseline and 2, 6, 12, and 24 weeks after their chosen quit day and participated in structured user feedback sessions 2 weeks after their chosen quit day. ResultsApp usage during the prescribed 3 weeks of use was high, with an average 84% (25.2/30) of participants using the app on any given day. App use was largely driven by completing happiness exercises (73%, 22/30) of participants per day), which participants continued to complete even after the end of the prescribed period. At the end of prescribed use, 90% (27/30) of participants reported that the app had helped them during their quit attempt, primarily by reminding them to stay on track (83%, 25/30) and boosting their confidence to quit (80%, 24/30) and belief that quitting was worthwhile (80%, 24/30). Happiness exercises were rated more favorably than user-initiated smoking cessation tools, and 80% (24/30) of participants proactively expressed in interviews that they liked them. App functionality to engage social support was not well received. Functionality to deal with risky times was rated useful but was rarely used. Within-person changes from baseline to the end of prescribed use were observed for several theorized mechanisms of behavior change, all in the expected direction: confidence increased (on a 0-100 scale, internal cues: b=16.7, 95% CI 7.2 to 26.3, P=.001; external cues: b=15.8, 95% CI 5.4 to 26.1, P=.004), urge to smoke decreased (on a 1-7 scale, b=−0.8, 95% CI −1.3 to −0.3, P=.002), and perceptions of smoking became less positive (on a 1-5 scale, psychoactive benefits: b=−0.5, 95% CI −0.9 to −0.2, P=.006; pleasure: b=−0.4, 95% CI −0.7 to −0.01, P=.03; on a 0-100 scale, importance of pros of smoking: b=−11.3, 95% CI −18.9 to −3.8, P=.004). Self-reported abstinence rates were 40% (12/30) and 53% (16/30) of participants 2 and 24 weeks post quit, respectively, with 30% (9/30) biochemically validated as abstinent 2 weeks post quit. ConclusionsA smartphone app using happiness exercises to aid smoking cessation was well received by nondaily smokers. Given the high nonadherence and dropout rates for technology-delivered interventions reported in the literature, the high engagement with positive psychology exercises is noteworthy. Observed within-person changes and abstinence rates are promising and warrant further development of this app.
- Published
- 2019
39. Effectiveness of a Disability Preventive Intervention for Minority and Immigrant Elders: The Positive Minds-Strong Bodies Randomized Clinical Trial
- Author
-
Naihua Duan, Aida L. Jiménez, Yuying Guo, Zorangeli Ramos, Lizbeth Herrera, Janet Pan, Larimar Fuentes, Stephen J. Bartels, Giselle K. Perez, Walter R. Frontera, Jeanine Wong, Mario Cruz-Gonzalez, Urania Genatios, Ye Wang, Ching King Chieng, Esther Velazquez, Chau Trinh-Shevrin, Sheri Lapatin Markle, Margarita Alegría, Rachel Zack Ishikawa, Patrick E. Shrout, Megan Cheung, and Josephine Yankau Wong
- Subjects
Male ,medicine.medical_specialty ,medicine.medical_treatment ,Health Status ,Psychological intervention ,Emigrants and Immigrants ,Patient Health Questionnaire ,Article ,White People ,law.invention ,03 medical and health sciences ,Disability Evaluation ,0302 clinical medicine ,Randomized controlled trial ,law ,Intervention (counseling) ,Activities of Daily Living ,Medicine ,Humans ,Disabled Persons ,Exercise ,Depression (differential diagnoses) ,Minority Groups ,Aged ,Community Health Workers ,030214 geriatrics ,Asian ,Cognitive Behavioral Therapy ,business.industry ,Attendance ,Hispanic or Latino ,Middle Aged ,Patient Acceptance of Health Care ,Physical Functional Performance ,Cognitive behavioral therapy ,Black or African American ,Psychiatry and Mental health ,Mood ,Mental Health ,Patient Satisfaction ,Physical therapy ,Anxiety ,Feasibility Studies ,Female ,Preventive Medicine ,Geriatrics and Gerontology ,medicine.symptom ,business - Abstract
Objective To test the acceptability and effectiveness of a disability prevention intervention, Positive Minds-Strong Bodies (PMSB), offered by paraprofessionals to mostly immigrant elders in four languages. Design Randomized trial of 307 participants, equally randomized into intervention or enhanced usual care. Setting Community-based organizations in Massachusetts, New York, Florida, and Puerto Rico serving minority elders. Data collected at baseline, 2, 6, and 12 months, between May 2015 and March 2019. Participants English-, Spanish-, Mandarin-, or Cantonese-speaking adults, age 60+, not seeking disability prevention services, but eligible per elevated mood symptoms and minor to moderate physical dysfunction. Interventions Ten individual sessions of cognitive behavioral therapy (PM) concurrently offered with 36 group sessions of strengthening exercise training (SB) over 6 months compared to enhanced usual care. Measurements Acceptability defined as satisfaction and attendance to >50% of sessions. Effectiveness determined by changes in mood symptoms (HSCL-25 and GAD-7), functional performance (SPPB), self-reported disability (LLFDI), and disability days (WHODAS 2.0). Results Around 77.6% of intervention participants attended over half of PM Sessions; 53.4% attended over half of SB sessions. Intent-to-treat analyses at 6 months showed significant intervention effects: improved functioning per SPPB and LLFDI, and lowered mood symptoms per HSCL-25. Intent-to-treat analyses at 12 months showed that effects remained significant for LLFDI and HSCL-25, and disability days (per WHODAS 2.0) significantly decreased 6-month after the intervention. Conclusions PMSB offered by paraprofessionals in community-based organizations demonstrates good acceptability and seems to improve functioning, with a compliance-benefit effect showing compliance as an important determinant of the intervention response.
- Published
- 2019
40. Leveraging Positive Psychology to Support Smoking Cessation in Nondaily Smokers Using a Smartphone App: Feasibility and Acceptability Study (Preprint)
- Author
-
Bettina B Hoeppner, Susanne S Hoeppner, Hannah A Carlon, Giselle K Perez, Eric Helmuth, Christopher W Kahler, and John F Kelly
- Abstract
BACKGROUND Nondaily smoking is an increasingly prevalent smoking pattern that poses substantial health risks. OBJECTIVE We tested the feasibility of using a smartphone app with positive psychology exercises to support smoking cessation in nondaily smokers. METHODS In this prospective, single-group pilot study, nondaily smokers (n=30) used version 1 of the Smiling Instead of Smoking (SiS) app for 3 weeks while undergoing a quit attempt. The app assigned daily happiness exercises, provided smoking cessation tools, and made smoking cessation information available. Participants answered surveys at baseline and 2, 6, 12, and 24 weeks after their chosen quit day and participated in structured user feedback sessions 2 weeks after their chosen quit day. RESULTS App usage during the prescribed 3 weeks of use was high, with an average 84% (25.2/30) of participants using the app on any given day. App use was largely driven by completing happiness exercises (73%, 22/30) of participants per day), which participants continued to complete even after the end of the prescribed period. At the end of prescribed use, 90% (27/30) of participants reported that the app had helped them during their quit attempt, primarily by reminding them to stay on track (83%, 25/30) and boosting their confidence to quit (80%, 24/30) and belief that quitting was worthwhile (80%, 24/30). Happiness exercises were rated more favorably than user-initiated smoking cessation tools, and 80% (24/30) of participants proactively expressed in interviews that they liked them. App functionality to engage social support was not well received. Functionality to deal with risky times was rated useful but was rarely used. Within-person changes from baseline to the end of prescribed use were observed for several theorized mechanisms of behavior change, all in the expected direction: confidence increased (on a 0-100 scale, internal cues: b=16.7, 95% CI 7.2 to 26.3, P=.001; external cues: b=15.8, 95% CI 5.4 to 26.1, P=.004), urge to smoke decreased (on a 1-7 scale, b=−0.8, 95% CI −1.3 to −0.3, P=.002), and perceptions of smoking became less positive (on a 1-5 scale, psychoactive benefits: b=−0.5, 95% CI −0.9 to −0.2, P=.006; pleasure: b=−0.4, 95% CI −0.7 to −0.01, P=.03; on a 0-100 scale, importance of pros of smoking: b=−11.3, 95% CI −18.9 to −3.8, P=.004). Self-reported abstinence rates were 40% (12/30) and 53% (16/30) of participants 2 and 24 weeks post quit, respectively, with 30% (9/30) biochemically validated as abstinent 2 weeks post quit. CONCLUSIONS A smartphone app using happiness exercises to aid smoking cessation was well received by nondaily smokers. Given the high nonadherence and dropout rates for technology-delivered interventions reported in the literature, the high engagement with positive psychology exercises is noteworthy. Observed within-person changes and abstinence rates are promising and warrant further development of this app.
- Published
- 2019
41. Health uncertainty among healthcare workers during the COVID-19 pandemic
- Author
-
Louisa G. Sylvia, Christina M. Luberto, Elyse R. Park, Daphne J. Holt, Giselle K. Perez, Nicole R. DeTore, Helen Mizrach, Nevita George, Alexandros Markowitz, Gregory L. Fricchione, and Daniel L. Hall
- Subjects
Gerontology ,Coping (psychology) ,business.industry ,Health care ,Psychological intervention ,medicine ,Anxiety ,Loneliness ,Computer-assisted web interviewing ,medicine.symptom ,business ,Mental health ,Depression (differential diagnoses) - Abstract
Objective: Health uncertainty among healthcare workers has yet to be examined as a contributor to the psychological toll of the COVID-19 pandemic. We aimed to (1) characterize health uncertainty levels among healthcare workers in a large, U.S. hospital system during the COVID-19 pandemic and (2) examine associations between health uncertainty and psychological outcomes.Methods: From March to June 2020, healthcare workers in a large, urban U.S. healthcare system were invited to complete an online questionnaire. Self-report measures assessed sociodemographic characteristics and job roles, health uncertainty, and emotional wellbeing variables (anxiety, depression, loneliness, self-compassion, and coping confidence). Health uncertainty (categorical and continuous scores) was compared across each variable using correlations and ANOVAs.Results: Healthcare workers (N = 440) were on average 44.5 years of age, 88.9% female, and 84.5% non-Hispanic white. Over half (52%) endorsed experiencing health uncertainty “sometimes” to “all the time”. While unrelated to sociodemographic characteristics (ps > .05), health uncertainty was highest among pharmacists and technicians, with levels significantly higher than other roles including physicians (p < .05) and mental health and spiritual counselors (p < .05). Higher health uncertainty was associated with higher anxiety (p < .001), depression (p < .001), and loneliness (p < .001), higher self-compassion (p = .02), and lower coping confidence (p < .001).Conclusions: Health uncertainty during the COVID-19 pandemic is common among healthcare workers, with higher levels related to poorer emotional wellbeing and less confidence in their coping abilities. Further research is needed to understand the relationships between healthcare workers’ health uncertainties and associated factors (i.e., job roles) and to identify whether health uncertainty may be a modifiable target for future interventions.
- Published
- 2021
42. Examining the effects of problematic alcohol use on cigarette abstinence in recently diagnosed cancer patients enrolled in a cessation trial: A secondary analysis
- Author
-
Jamie S. Ostroff, Joanna M. Streck, Colin Ponzani, Giselle K. Perez, Nancy A. Rigotti, Elyse R. Park, Sara Kalkhoran, Susan Regan, Kelly A. Hyland, and Alona Muzikansky
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,media_common.quotation_subject ,030508 substance abuse ,Medicine (miscellaneous) ,Binge drinking ,Alcohol ,Toxicology ,Logistic regression ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Neoplasms ,Internal medicine ,medicine ,Humans ,030212 general & internal medicine ,media_common ,business.industry ,Standard treatment ,Smoking ,Cancer ,Tobacco Products ,Abstinence ,medicine.disease ,Tobacco Use Cessation Devices ,Clinical trial ,Psychiatry and Mental health ,Clinical Psychology ,chemistry ,Smoking cessation ,Smoking Cessation ,0305 other medical science ,business - Abstract
Aims Among people with cancer, dual alcohol and tobacco use increases risk for morbidity and mortality. Most smoking cessation clinical trials with this patient population have excluded individuals with problematic alcohol use. This investigation examined whether problematic alcohol use affects smoking cessation in cancer patients. Methods Mixed-methods secondary analysis of data from the Smokefree Support Study, a randomized-controlled trial examining the efficacy of Intensive (IT; n = 153) vs. Standard Treatment (ST; n = 150) for smoking cessation in newly diagnosed cancer patients. Problematic alcohol use was assessed at enrollment using the Cut-Down-Annoyed-Guilty-Eye-Opener (CAGE), weekly frequency of alcohol use and binge drinking measures. Alcohol use was categorized as: no current alcohol use, moderate and problematic use. The primary outcome was biochemically-confirmed cigarette abstinence at 6-months. A subset of patients (n = 72) completed qualitative exit-interviews. Results Among all participants, biochemically-confirmed cigarette abstinence rates were 25% (n = 32), 28% (n = 27), and 36% (n = 20) for participants reporting no current alcohol use, moderate use, and problematic use, respectively (p = 0.33). In logistic regression analysis, neither problematic alcohol use (AOR = 0.96, 95% CI = 0.35–2.67, p = .94) nor the problematic use by study arm interaction (AOR = 2.22, 95% CI = 0.59–8.39, p = .24) were associated with biochemically-confirmed 6-month abstinence. Qualitatively, participants reported that drinking alcohol triggers urges to smoke. Conclusion Newly diagnosed cancer patients reporting problematic alcohol use were not less likely to quit smoking than those without. Additional research is needed to investigate whether problematic alcohol users may benefit from smoking and alcohol behavior change interventions at the time of cancer diagnosis.
- Published
- 2021
43. Abstract IA21: Addressing gaps in health insurance literacy among adolescent and young adult cancer patients
- Author
-
Tomoko Tsukamoto, Austin R. Waters, Elyse R. Park, Nicole Ray, Echo L. Warner, Heydon K. Kaddas, Perla L. Vaca Lopez, Anne C. Kirchhoff, Giselle K. Perez, Mark A. Lewis, Karely Mann, and Doug Fair
- Subjects
Gerontology ,Oncology ,Epidemiology ,business.industry ,media_common.quotation_subject ,Health insurance ,Medicine ,Cancer ,Young adult ,business ,medicine.disease ,Literacy ,media_common - Abstract
Background: Adolescent and young adult (AYA) cancer patients commonly report health insurance concerns and financial burden that emerge due to their cancer treatment. AYAs often have limited experience with health care prior to their cancer diagnosis, which may limit their understanding of health insurance concepts and affect their medical costs. As part of the development of an insurance navigation program, we conducted an evaluation of health insurance experiences, expectations, and literacy among a sample of AYA cancer patients. Methods: Eligible participants were 18-39 years of age with cancer, and currently insured. Participants were recruited in-person and online through a statewide AYA cancer navigation program in Utah. We selected the sample stratified on current age (18-25 and 26-39 years). Participants completed a brief survey and a semi-structured interview. We summarized demographic factors and the Health Insurance Literacy Measure (HILM), a continuous measure ranging from 0-84. The HILM score was examined by age (18-25 vs. 26-39 years) and insurance policy holder (yes vs. no) using t-tests. The semi-structured interviews were recorded, transcribed, and analyzed. Two cycles of inductive coding were applied to open-ended questions regarding health insurance knowledge, areas of confusion, their coverage expectations, and their experiences with medical costs. Results: Of AYA participants, N=13 were 18-25 and N=11 were 26-29 years; participants were female (58%) and Non-Hispanic White (79%), and most had completed at least had some college (92%). Less than half of participants were policy holders for their health insurance (41.7%). Mean HILM score was 55.63 (SD=10.06). There were no differences in the HILM measure by age or policy holder status. Three emergent qualitative themes included: 1) Lack of insurance knowledge affected experiences throughout treatment. While some AYAs understood the basics of their insurance coverage, most were unaware of the specifics of their plan, including how their coverage impacted their out-of-pocket costs. 2) Unclear expectations of health insurance. Most AYA participants were unsure what their health insurance should cover, but at the same time, were surprised about the lack of coverage and high costs. 3) Difficulties navigating coverage and the complexity of the health care system. Most AYAs reported struggled with handling insurance coverage issues, particularly when appeals were necessary to have their health care covered. Conclusions: AYAs with cancer report difficulty navigating the complexities of health insurance and lack understanding about what services their insurance should cover. Education focusing on insurance concepts (e.g., cost-sharing mechanisms such as deductibles) and areas where out-of-pocket costs could be managed (e.g., appeals process, in- vs. out-of-network services) could help AYA cancer patients make more informed health insurance decisions during their cancer treatment. Citation Format: Anne C. Kirchhoff, Karely Mann, Austin R. Waters, Echo L. Warner, Perla Vaca Lopez, Heydon K. Kaddas, Nicole Ray, Tomoko Tsukamoto, Doug Fair, Mark Lewis, Giselle K Perez, Elyse R. Park. Addressing gaps in health insurance literacy among adolescent and young adult cancer patients [abstract]. In: Proceedings of the AACR Virtual Conference: Thirteenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2020 Oct 2-4. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2020;29(12 Suppl):Abstract nr IA21.
- Published
- 2020
44. A brief information–motivation–behavioral skills intervention to promote human papillomavirus vaccination among college-aged women
- Author
-
Nicole M Strauss, Giselle K. Perez, and Dean G. Cruess
- Subjects
HPV ,medicine.medical_specialty ,cervical cancer ,HPV vaccines ,Odds ,IMB ,03 medical and health sciences ,Gardasil ,0302 clinical medicine ,Intervention (counseling) ,medicine ,030212 general & internal medicine ,human papillomavirus ,General Psychology ,Original Research ,Cervical cancer ,Gynecology ,030505 public health ,business.industry ,Attentional control ,Cancer ,vaccination ,medicine.disease ,Vaccination ,Psychiatry and Mental health ,Psychology Research and Behavior Management ,Family medicine ,0305 other medical science ,business ,medicine.drug - Abstract
Giselle K Perez,1 Dean G Cruess,2 Nicole M Strauss,3 1Department of Psychiatry, Massachusetts General Hospital, Boston, MA, 2Department of Psychology, University of Connecticut, Storrs, CT, 3Mongan Institute for Health Policy, Massachusetts General Hospital, Boston, MA, USA Background: Human papillomavirus (HPV) is prevalent among college-aged women. Although HPV vaccines decrease women’s risk for cervical cancer, the vaccination rates remain inadequate. Objective: This study explored the utility of an information–motivation–behavioral skills (IMB) intervention in promoting HPV vaccination knowledge, motivation, and intentions among college-aged women. Methods: In Spring/Fall 2012, 62 participants were randomly assigned to a single-session intervention or attention control and were assessed baseline, post-intervention, and at 1month. Results: The participants demonstrated adequate baseline vaccine knowledge, low HPV/cancer knowledge, and ambivalence about the vaccination. Post-intervention, the IMB arm demonstrated increased HPV/cancer and vaccination knowledge, motivation, and intentions. There were no group differences in vaccination at 1month; however, the odds of wanting to get vaccinated increased sevenfold in the IMB arm. Conclusion: These results provide preliminary support for an IMB-based intervention in increasing vaccination knowledge, motivation, and intentions among at-risk women. Future research examining the efficacy of longer trials with larger, diverse populations is warranted. Keywords: human papillomavirus, HPV, vaccination, cervical cancer, Gardasil, IMB
- Published
- 2016
45. Integrating tobacco treatment into cancer care: Study protocol for a randomized controlled comparative effectiveness trial
- Author
-
Douglas E. Levy, Nancy A. Rigotti, Irina Gonzalez, Julia Rabin, Jacob Miller-Sobel, Kelly A. Hyland, Emily Friedman, Lisa Peterson, C. Will Whitlock, Alona Muzikansky, Jamie S. Ostroff, Susan Holland, Justin Eusebio, Giselle K. Perez, Elyse R. Park, Maureen O'Brien, Sarah P. Borderud, Suhana de León-Sanchez, Laura Malloy, and Susan Regan
- Subjects
Counseling ,Male ,Research design ,Comparative Effectiveness Research ,Health Knowledge, Attitudes, Practice ,medicine.medical_specialty ,Cost-Benefit Analysis ,medicine.medical_treatment ,Emotions ,Comparative effectiveness research ,Psychological intervention ,Cancer Care Facilities ,Environment ,Article ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Neoplasms ,medicine ,Humans ,Pharmacology (medical) ,030212 general & internal medicine ,business.industry ,Standard treatment ,General Medicine ,Tobacco Use Cessation Devices ,Socioeconomic Factors ,Research Design ,030220 oncology & carcinogenesis ,Family medicine ,Quality of Life ,Physical therapy ,Smoking cessation ,Female ,Smoking Cessation ,Tobacco Use Cessation Products ,business - Abstract
Background Despite the well-established risks of persistent smoking, 10–30% of cancer patients continue to smoke after diagnosis. Evidence-based tobacco treatment has yet to be integrated into routine oncology care. This paper describes the protocol, manualized treatment, evaluation plan, and overall study design of comparing the effectiveness and cost of two treatments across two major cancer centers. Methods/design A two-arm, two-site randomized controlled comparative effectiveness trial is testing the hypothesis that an Intensive Treatment (IT) intervention is more effective than a Standard Treatment (ST) intervention in helping recently diagnosed cancer patients quit smoking. Both interventions include 4 weekly counseling sessions and FDA-approved smoking cessation medication advice. The IT includes an additional 4 biweekly and 3 monthly booster sessions as well as dispensal of the recommended FDA-approved smoking cessation medication at no cost. The trial is enrolling patients with suspected or newly diagnosed cancer who have smoked a cigarette in the past 30 days. Participants are randomly assigned to receive the ST or IT condition. Tobacco cessation outcomes are assessed at 3 and 6 months. The primary study outcome is 7-day point prevalence biochemically-validated tobacco abstinence. Secondary study outcomes include the incremental cost-effectiveness of the IT vs. ST. Discussion This trial will answer key questions about delivering tobacco treatment interventions to newly diagnosed cancer patients. If found to be efficacious and cost-effective, this treatment will serve as a model to be integrated into oncology care settings nation-wide, as we strive to improve treatment outcomes and quality of life for cancer patients.
- Published
- 2016
46. Promoting quality care in patients with cancer with limited English proficiency: perspectives of medical interpreters
- Author
-
Mai See Yang, Elyse R. Park, Jan E. Mutchler, Cheyenne Fox Tree-Mcgrath, and Giselle K. Perez
- Subjects
medicine.medical_specialty ,business.industry ,Cancer ,Quality care ,Experimental and Cognitive Psychology ,medicine.disease ,computer.software_genre ,03 medical and health sciences ,Psychiatry and Mental health ,0302 clinical medicine ,Oncology ,030220 oncology & carcinogenesis ,Limited English proficiency ,Family medicine ,medicine ,In patient ,030212 general & internal medicine ,business ,computer ,Interpreter - Published
- 2016
47. Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial
- Author
-
Pallavi Kumar, Christopher S. Lathan, Ilana F. Gareen, Elyse R. Park, Giselle K. Perez, JoRean D. Sicks, and Kelly A. Hyland
- Subjects
Male ,Cancer Research ,medicine.medical_specialty ,Lung Neoplasms ,media_common.quotation_subject ,medicine.medical_treatment ,White People ,03 medical and health sciences ,0302 clinical medicine ,Surveys and Questionnaires ,Cancer screening ,medicine ,Humans ,030212 general & internal medicine ,Lung cancer ,Early Detection of Cancer ,Disease burden ,Aged ,media_common ,business.industry ,Smoking ,Community Outreach ,Odds ratio ,Middle Aged ,Abstinence ,medicine.disease ,respiratory tract diseases ,Black or African American ,Oncology ,030220 oncology & carcinogenesis ,Family medicine ,behavior and behavior mechanisms ,Smoking cessation ,Female ,Smoking Cessation ,National Lung Screening Trial ,business ,Lung cancer screening ,Demography - Abstract
Background. Black smokers have demonstrated greater lung cancer disease burden and poorer smoking cessation outcomes compared with whites. Lung cancer screening represents a unique opportunity to promote cessation among smokers; however, little is known about the differential impact of screening on smoking behaviors among black and white smokers. Using data from the National Lung Screening Trial (NLST), we examined the racial differences in smoking behaviors after screening. Methods. We examined racial differences in smoking behavior and cessation activity among 6,316 white and 497 black (median age, 60 and 59 years, respectively) NLST participants who were current smokers at screening using a follow-up survey on 24-hour and 7-day quit attempts, 6-month continuous abstinence, and the use of smoking cessation programs and aids at 12 months after screening. Using multiple regression analyses, we examined the predictors of 24-hour and 7-day quit attempts and 6-month continuous abstinence. Results. At 12 months after screening, blacks were more likely to report a 24-hour (52.7% vs. 41.2%, p < .0001) or 7-day (33.6% vs. 27.2%, p = .002) quit attempt. However, no significant racial differences were found in 6-month continuous abstinence (5.6% blacks vs. 7.2% whites). In multiple regression, black race was predictive of a higher likelihood of a 24-hour (odds ratio [OR], 1.6, 95% confidence interval [CI], 1.2–2.0) and 7-day (OR, 1.5, 95% CI, 1.1–1.8) quit attempt; however, race was not associated with 6-month continuous abstinence. Only a positive screening result for lung cancer was significantly predictive of successful 6-month continuous abstinence (OR, 2.3, 95% CI, 1.8–2.9). Conclusion. Although blacks were more likely than whites to have 24-hour and 7-day quit attempts, the rates of 6-month continuous abstinence did not differ. Targeted interventions are needed at the time of lung cancer screening to promote abstinence among all smokers.
- Published
- 2015
48. Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer
- Author
-
Irina Gonzalez, Colin Ponzani, Kelly A. Hyland, Nancy A. Rigotti, Alona Muzikansky, Mary E. Cooley, Giselle K. Perez, Douglas E. Levy, Kim Sprunck, Jamie S. Ostroff, Kelly E. Irwin, Emily Friedman, Diana Kwon, Jacob Miller-Sobel, Sarah P. Borderud, Suhana de León-Sanchez, Lisa Peterson, C. Will Whitlock, Julia Rabin, Maureen O'Brien, Laura Malloy, Susan Regan, Ann H. Partridge, Elyse R. Park, Jennifer S. Temel, Susan Holland, and William F. Pirl
- Subjects
Counseling ,Male ,Temperance ,medicine.medical_treatment ,Health Behavior ,Motivational interviewing ,01 natural sciences ,law.invention ,chemistry.chemical_compound ,0302 clinical medicine ,Randomized controlled trial ,law ,Neoplasms ,030212 general & internal medicine ,Cotinine ,Varenicline ,Original Investigation ,media_common ,Smoking Cessation Agents ,Standard treatment ,Smoking ,General Medicine ,Middle Aged ,Tobacco Use Cessation Devices ,Patient Satisfaction ,Female ,medicine.medical_specialty ,media_common.quotation_subject ,Motivational Interviewing ,Decision Support Techniques ,03 medical and health sciences ,Telephone counseling ,Internal medicine ,medicine ,Humans ,0101 mathematics ,Saliva ,Bupropion ,Aged ,business.industry ,Patient Selection ,010102 general mathematics ,Abstinence ,Nicotine replacement therapy ,Telephone ,chemistry ,Smoking cessation ,Smoking Cessation ,business - Abstract
IMPORTANCE: Persistent smoking may cause adverse outcomes among patients with cancer. Many cancer centers have not fully implemented evidence-based tobacco treatment into routine care. OBJECTIVE: To determine the effectiveness of sustained telephone counseling and medication (intensive treatment) compared with shorter-term telephone counseling and medication advice (standard treatment) to assist patients recently diagnosed with cancer to quit smoking. DESIGN, SETTING, AND PARTICIPANTS: This unblinded randomized clinical trial was conducted at Massachusetts General Hospital/Dana-Farber/Harvard Cancer Center and Memorial Sloan Kettering Cancer Center. Adults who had smoked 1 cigarette or more within 30 days, spoke English or Spanish, and had recently diagnosed breast, gastrointestinal, genitourinary, gynecological, head and neck, lung, lymphoma, or melanoma cancers were eligible. Enrollment occurred between November 2013 and July 2017; assessments were completed by the end of February 2018. INTERVENTIONS: Participants randomized to the intensive treatment (n = 153) and the standard treatment (n = 150) received 4 weekly telephone counseling sessions and medication advice. The intensive treatment group also received 4 biweekly and 3 monthly telephone counseling sessions and choice of Food and Drug Administration–approved cessation medication (nicotine replacement therapy, bupropion, or varenicline). MAIN OUTCOME AND MEASURES: The primary outcome was biochemically confirmed 7-day point prevalence tobacco abstinence at 6-month follow-up. Secondary outcomes were treatment utilization rates. RESULTS: Among 303 patients who were randomized (mean age, 58.3 years; 170 women [56.1%]), 221 (78.1%) completed the trial. Six-month biochemically confirmed quit rates were 34.5% (n = 51 in the intensive treatment group) vs 21.5% (n = 29 in the standard treatment group) (difference, 13.0% [95% CI, 3.0%-23.3%]; odds ratio, 1.92 [95% CI, 1.13-3.27]; P
- Published
- 2020
49. Adolescent and young adult cancer patients' health insurance experiences, expectations, and literacy
- Author
-
Nicole Ray, Giselle K. Perez, Elyse R. Park, Perla L. Vaca Lopez, Mark A. Lewis, Austin R. Waters, Echo L. Warner, Karely Mann, Tomoko Tsukamoto, Anne C. Kirchhoff, Douglas Fair, and Heydon K. Kaddas
- Subjects
Gerontology ,Cancer Research ,business.industry ,media_common.quotation_subject ,Cancer ,medicine.disease ,humanities ,Literacy ,Oncology ,Health insurance ,medicine ,Young adult ,business ,media_common - Abstract
65 Background: Adolescent and young adult (AYA) cancer patients (15-39 years of age) often report health insurance concerns and financial toxicity due to their life-saving treatment. AYAs often have limited experience with healthcare prior to their diagnosis, which may limit their understanding of health insurance concepts, coverage, and costs. To describe AYA health insurance experiences, expectations, and literacy, we conducted semi-structured interviews with AYA cancer patients and survivors. Methods: Eligible participants were 18-39 years, diagnosed with cancer, and insured. Participants were recruited through an AYA cancer navigation program in Utah from 10/2019-03/2020. Participants were purposively sampled to achieve equal age strata (18-25 vs. 26-39), as patients under 26 often remain on their parents policy. Individual interviews were recorded, transcribed, and analyzed. Inductive qualitative analysis was conducted to describe their experiences with and understanding of their insurance. We calculated descriptive statistics of demographics and the Health Insurance Literacy Measure (HILM), a continuous measure ranging from 0-84 (higher scores indicate higher comfortability and literacy). Associations of age (18-25 vs. 26-39) and policy holder (yes vs. no) with HILM score were evaluated with t-tests. Results: AYAs (N = 24) were nearly even by gender, female (58%), primarily heterosexual (92%), Non-Hispanic White (79%), and had at least some college (92%). Less than half of participants were policy holders (41.7%). Three themes emerged from analysis: 1) Lack of knowledge and experiential learning throughout treatment, 2) Unclear expectations of health insurance, and 3) Difficulties navigating coverage and the complex systems. Most AYAs were unaware of the specifics of their coverage and how their insurance plan impacted their costs. Most AYAs were surprised at the lack of coverage and high costs they encountered during treatment. Most AYAs experienced substantial difficulty navigating coverage issues, particularly the appeals process. The mean HILM score was 55.63 (SD = 10.06), no differences by age group or policy holder status. Conclusions: AYAs with cancer report substantial difficulty navigating the complex health insurance system and demonstrate low levels of health insurance literacy. Health insurance education focusing on insurance concepts (e.g., cost-sharing mechanisms) may help AYAs better manage costs and enable them to make informed health insurance decisions despite being at higher risk for financial toxicity.
- Published
- 2020
50. Financial burdens of insured adolescent and young adult cancer patients: A need for crowdfunding platforms, fundraisers, financial grants, and cost conversations with their cancer care team
- Author
-
Elyse R. Park, Karely Mann, Heydon K. Kaddas, Nicole Ray, Mark A. Lewis, Echo L. Warner, Austin R. Waters, Anne C. Kirchhoff, Giselle K. Perez, Perla L. Vaca Lopez, Douglas Fair, and Tomoko Tsukamoto
- Subjects
Gerontology ,Cancer Research ,Distress ,Oncology ,business.industry ,medicine ,Cancer ,Young adult ,medicine.disease ,business ,health care economics and organizations ,Underinsured - Abstract
83 Background: Cancer patients in the United States often experience distress surrounding out of pocket costs from treatment. Adolescents and young adults (AYA) are more likely to be underinsured, skip care due to cost, go into debt, and file for bankruptcy after a cancer diagnosis than patients diagnosed at older ages. We conducted semi-structured interviews with AYA cancer patients and survivors to evaluate their experiences with health insurance, cancer costs and use of crowdfunding. Methods: Eligible participants were ages 18-39, diagnosed with cancer, and currently insured. Recruitment occurred largely through patient navigators at two large cancer centers from October 2019 to March 2020. Data was collected via individual semi-structured telephone interviews, which were analyzed for content. Questions were asked pertaining to crowdfunding platforms, fundraisers, satisfaction with current health insurance policy, and cost conversations with their cancer care team. Interviews were analyzed applying two rounds of thematic content analysis. Summary statistics were calculated for demographics. Results: Twenty-four interviews were completed, with more than half of participants being female (58%), most participants being Non-Hispanic White (79%), mean age at 26.5, and currently receiving cancer treatment (79%). Three themes emerged about AYAs’ experience with treatment costs and health insurance: 1) Even with insurance, cancer care was unexpectedly expensive and burdensome on financial wellbeing; 2) Conversations about cost with cancer care teams were brief and rare and 3) Crowdfunding platforms, fundraisers or financial grants were often used as financial safety nets, and did not cover all out of pocket costs. More than half of participants expressed interest in having cost conversations with their oncologist, nurse or social worker. All participants expressed a need for education on managing cancer costs and a particular interest in educational information on appeals and out of pocket costs. Conclusions: AYAs with cancer report unexpected costs and are interested in discussing this with their cancer care team. AYAs often receive money from fundraisers, financial grants or crowdfunding platforms to assist with the expenses of treatment. Discussions between cancer care teams and AYA patients about health insurance policies and cost saving mechanisms may help reduce out of pocket costs and reliance on external financial mechanisms.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.